<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for na_pos 1605123464930 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='http://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/PASINI_SUZ12_TARGETS_DN'>PASINI_SUZ12_TARGETS_DN</a></td><td><a href='PASINI_SUZ12_TARGETS_DN.html'>Details ...</a></td><td>50</td><td>0.54</td><td>3.01</td><td>0.000</td><td>0.000</td><td>0.000</td><td>320</td><td>tags=92%, list=42%, signal=147%</td></tr><tr><td class='lessen'>2</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3'>KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3</a></td><td><a href='KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3.html'>Details ...</a></td><td>85</td><td>0.44</td><td>2.90</td><td>0.000</td><td>0.000</td><td>0.000</td><td>319</td><td>tags=78%, list=41%, signal=118%</td></tr><tr><td class='lessen'>3</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RICKMAN_METASTASIS_DN'>RICKMAN_METASTASIS_DN</a></td><td><a href='RICKMAN_METASTASIS_DN.html'>Details ...</a></td><td>22</td><td>0.61</td><td>2.67</td><td>0.000</td><td>0.000</td><td>0.000</td><td>164</td><td>tags=68%, list=21%, signal=84%</td></tr><tr><td class='lessen'>4</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DACOSTA_UV_RESPONSE_VIA_ERCC3_DN'>DACOSTA_UV_RESPONSE_VIA_ERCC3_DN</a></td><td><a href='DACOSTA_UV_RESPONSE_VIA_ERCC3_DN.html'>Details ...</a></td><td>36</td><td>0.49</td><td>2.53</td><td>0.000</td><td>0.001</td><td>0.003</td><td>334</td><td>tags=92%, list=43%, signal=154%</td></tr><tr><td class='lessen'>5</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/CHICAS_RB1_TARGETS_LOW_SERUM'>CHICAS_RB1_TARGETS_LOW_SERUM</a></td><td><a href='CHICAS_RB1_TARGETS_LOW_SERUM.html'>Details ...</a></td><td>19</td><td>0.61</td><td>2.48</td><td>0.000</td><td>0.004</td><td>0.010</td><td>314</td><td>tags=100%, list=41%, signal=165%</td></tr><tr><td class='lessen'>6</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KRIEG_HYPOXIA_NOT_VIA_KDM3A'>KRIEG_HYPOXIA_NOT_VIA_KDM3A</a></td><td><a href='KRIEG_HYPOXIA_NOT_VIA_KDM3A.html'>Details ...</a></td><td>51</td><td>0.43</td><td>2.45</td><td>0.000</td><td>0.004</td><td>0.012</td><td>337</td><td>tags=82%, list=44%, signal=137%</td></tr><tr><td class='lessen'>7</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MCBRYAN_PUBERTAL_BREAST_3_4WK_UP'>MCBRYAN_PUBERTAL_BREAST_3_4WK_UP</a></td><td><a href='MCBRYAN_PUBERTAL_BREAST_3_4WK_UP.html'>Details ...</a></td><td>29</td><td>0.52</td><td>2.42</td><td>0.000</td><td>0.005</td><td>0.017</td><td>148</td><td>tags=55%, list=19%, signal=66%</td></tr><tr><td class='lessen'>8</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/AMIT_EGF_RESPONSE_480_HELA'>AMIT_EGF_RESPONSE_480_HELA</a></td><td><a href='AMIT_EGF_RESPONSE_480_HELA.html'>Details ...</a></td><td>18</td><td>0.59</td><td>2.37</td><td>0.000</td><td>0.005</td><td>0.022</td><td>172</td><td>tags=72%, list=22%, signal=91%</td></tr><tr><td class='lessen'>9</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC'>KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC</a></td><td><a href='KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC.html'>Details ...</a></td><td>17</td><td>0.59</td><td>2.35</td><td>0.000</td><td>0.005</td><td>0.026</td><td>321</td><td>tags=100%, list=42%, signal=168%</td></tr><tr><td class='lessen'>10</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY'>WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY</a></td><td><a href='WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY.html'>Details ...</a></td><td>17</td><td>0.59</td><td>2.28</td><td>0.000</td><td>0.010</td><td>0.057</td><td>321</td><td>tags=100%, list=42%, signal=168%</td></tr><tr><td class='lessen'>11</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP'>RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP</a></td><td><a href='RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP.html'>Details ...</a></td><td>39</td><td>0.44</td><td>2.28</td><td>0.000</td><td>0.010</td><td>0.057</td><td>339</td><td>tags=85%, list=44%, signal=144%</td></tr><tr><td class='lessen'>12</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP'>JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP</a></td><td><a href='JINESH_BLEBBISHIELD_TRANSFORMED_STEM_CELL_SPHERES_UP.html'>Details ...</a></td><td>27</td><td>0.49</td><td>2.27</td><td>0.000</td><td>0.009</td><td>0.058</td><td>151</td><td>tags=56%, list=20%, signal=67%</td></tr><tr><td class='lessen'>13</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DURCHDEWALD_SKIN_CARCINOGENESIS_DN'>DURCHDEWALD_SKIN_CARCINOGENESIS_DN</a></td><td><a href='DURCHDEWALD_SKIN_CARCINOGENESIS_DN.html'>Details ...</a></td><td>24</td><td>0.50</td><td>2.26</td><td>0.000</td><td>0.009</td><td>0.065</td><td>312</td><td>tags=83%, list=41%, signal=136%</td></tr><tr><td class='lessen'>14</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KIM_WT1_TARGETS_UP'>KIM_WT1_TARGETS_UP</a></td><td><a href='KIM_WT1_TARGETS_UP.html'>Details ...</a></td><td>21</td><td>0.54</td><td>2.25</td><td>0.000</td><td>0.009</td><td>0.071</td><td>319</td><td>tags=90%, list=41%, signal=150%</td></tr><tr><td class='lessen'>15</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/KEGG_FOCAL_ADHESION'>KEGG_FOCAL_ADHESION</a></td><td><a href='KEGG_FOCAL_ADHESION.html'>Details ...</a></td><td>19</td><td>0.53</td><td>2.24</td><td>0.000</td><td>0.009</td><td>0.074</td><td>326</td><td>tags=95%, list=42%, signal=160%</td></tr><tr><td class='lessen'>16</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/WP_FOCAL_ADHESION'>WP_FOCAL_ADHESION</a></td><td><a href='WP_FOCAL_ADHESION.html'>Details ...</a></td><td>20</td><td>0.53</td><td>2.22</td><td>0.000</td><td>0.012</td><td>0.094</td><td>326</td><td>tags=95%, list=42%, signal=161%</td></tr><tr><td class='lessen'>17</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/BAE_BRCA1_TARGETS_UP'>BAE_BRCA1_TARGETS_UP</a></td><td><a href='BAE_BRCA1_TARGETS_UP.html'>Details ...</a></td><td>15</td><td>0.59</td><td>2.21</td><td>0.000</td><td>0.012</td><td>0.099</td><td>168</td><td>tags=73%, list=22%, signal=92%</td></tr><tr><td class='lessen'>18</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/DELYS_THYROID_CANCER_UP'>DELYS_THYROID_CANCER_UP</a></td><td><a href='DELYS_THYROID_CANCER_UP.html'>Details ...</a></td><td>43</td><td>0.41</td><td>2.21</td><td>0.000</td><td>0.012</td><td>0.105</td><td>141</td><td>tags=47%, list=18%, signal=54%</td></tr><tr><td class='lessen'>19</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN'>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN</a></td><td><a href='RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_DN.html'>Details ...</a></td><td>30</td><td>0.46</td><td>2.18</td><td>0.000</td><td>0.013</td><td>0.123</td><td>221</td><td>tags=63%, list=29%, signal=85%</td></tr><tr><td class='lessen'>20</td><td><a href='http://www.gsea-msigdb.org/gsea/msigdb/cards/MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP'>MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP</a></td><td><a href='MARTORIATI_MDM4_TARGETS_NEUROEPITHELIUM_UP.html'>Details ...</a></td><td>17</td><td>0.55</td><td>2.16</td><td>0.003</td><td>0.016</td><td>0.156</td><td>155</td><td>tags=65%, list=20%, signal=79%</td></tr><tr><td class='lessen'>21</td><td>BURTON_ADIPOGENESIS_8</td><td></td><td>16</td><td>0.54</td><td>2.15</td><td>0.000</td><td>0.017</td><td>0.173</td><td>195</td><td>tags=63%, list=25%, signal=82%</td></tr><tr><td class='lessen'>22</td><td>SENESE_HDAC3_TARGETS_UP</td><td></td><td>25</td><td>0.48</td><td>2.15</td><td>0.000</td><td>0.016</td><td>0.175</td><td>338</td><td>tags=88%, list=44%, signal=152%</td></tr><tr><td class='lessen'>23</td><td>BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B</td><td></td><td>44</td><td>0.38</td><td>2.10</td><td>0.004</td><td>0.021</td><td>0.232</td><td>121</td><td>tags=36%, list=16%, signal=41%</td></tr><tr><td class='lessen'>24</td><td>SMID_BREAST_CANCER_BASAL_UP</td><td></td><td>39</td><td>0.39</td><td>2.10</td><td>0.000</td><td>0.020</td><td>0.232</td><td>325</td><td>tags=77%, list=42%, signal=126%</td></tr><tr><td class='lessen'>25</td><td>YAMAZAKI_TCEB3_TARGETS_DN</td><td></td><td>23</td><td>0.47</td><td>2.09</td><td>0.000</td><td>0.020</td><td>0.240</td><td>79</td><td>tags=39%, list=10%, signal=42%</td></tr><tr><td class='lessen'>26</td><td>KARLSSON_TGFB1_TARGETS_UP</td><td></td><td>17</td><td>0.53</td><td>2.09</td><td>0.000</td><td>0.020</td><td>0.244</td><td>272</td><td>tags=88%, list=35%, signal=134%</td></tr><tr><td class='lessen'>27</td><td>REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA</td><td></td><td>15</td><td>0.56</td><td>2.09</td><td>0.003</td><td>0.021</td><td>0.257</td><td>304</td><td>tags=93%, list=40%, signal=151%</td></tr><tr><td class='lessen'>28</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_FIBROBLAST</td><td></td><td>39</td><td>0.38</td><td>2.08</td><td>0.000</td><td>0.020</td><td>0.261</td><td>144</td><td>tags=41%, list=19%, signal=48%</td></tr><tr><td class='lessen'>29</td><td>DAZARD_UV_RESPONSE_CLUSTER_G1</td><td></td><td>20</td><td>0.49</td><td>2.08</td><td>0.000</td><td>0.020</td><td>0.272</td><td>265</td><td>tags=80%, list=34%, signal=119%</td></tr><tr><td class='lessen'>30</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_DN</td><td></td><td>48</td><td>0.37</td><td>2.07</td><td>0.000</td><td>0.020</td><td>0.276</td><td>197</td><td>tags=46%, list=26%, signal=58%</td></tr><tr><td class='lessen'>31</td><td>LEE_LIVER_CANCER_SURVIVAL_DN</td><td></td><td>31</td><td>0.42</td><td>2.07</td><td>0.000</td><td>0.020</td><td>0.287</td><td>254</td><td>tags=65%, list=33%, signal=92%</td></tr><tr><td class='lessen'>32</td><td>DARWICHE_PAPILLOMA_RISK_HIGH_UP</td><td></td><td>23</td><td>0.46</td><td>2.07</td><td>0.000</td><td>0.020</td><td>0.290</td><td>122</td><td>tags=43%, list=16%, signal=50%</td></tr><tr><td class='lessen'>33</td><td>LI_INDUCED_T_TO_NATURAL_KILLER_UP</td><td></td><td>47</td><td>0.37</td><td>2.06</td><td>0.000</td><td>0.020</td><td>0.296</td><td>171</td><td>tags=40%, list=22%, signal=49%</td></tr><tr><td class='lessen'>34</td><td>DARWICHE_PAPILLOMA_RISK_LOW_UP</td><td></td><td>24</td><td>0.44</td><td>2.06</td><td>0.003</td><td>0.020</td><td>0.304</td><td>122</td><td>tags=46%, list=16%, signal=53%</td></tr><tr><td class='lessen'>35</td><td>ZWANG_CLASS_1_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>28</td><td>0.43</td><td>2.06</td><td>0.000</td><td>0.019</td><td>0.308</td><td>279</td><td>tags=75%, list=36%, signal=113%</td></tr><tr><td class='lessen'>36</td><td>BERENJENO_TRANSFORMED_BY_RHOA_UP</td><td></td><td>48</td><td>0.37</td><td>2.04</td><td>0.000</td><td>0.022</td><td>0.349</td><td>279</td><td>tags=65%, list=36%, signal=95%</td></tr><tr><td class='lessen'>37</td><td>GRUETZMANN_PANCREATIC_CANCER_UP</td><td></td><td>47</td><td>0.38</td><td>2.02</td><td>0.000</td><td>0.024</td><td>0.384</td><td>140</td><td>tags=43%, list=18%, signal=49%</td></tr><tr><td class='lessen'>38</td><td>MCBRYAN_PUBERTAL_BREAST_4_5WK_UP</td><td></td><td>46</td><td>0.38</td><td>2.02</td><td>0.000</td><td>0.023</td><td>0.384</td><td>148</td><td>tags=43%, list=19%, signal=51%</td></tr><tr><td class='lessen'>39</td><td>PECE_MAMMARY_STEM_CELL_UP</td><td></td><td>33</td><td>0.40</td><td>2.02</td><td>0.000</td><td>0.023</td><td>0.384</td><td>250</td><td>tags=58%, list=33%, signal=82%</td></tr><tr><td class='lessen'>40</td><td>COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP</td><td></td><td>15</td><td>0.55</td><td>2.02</td><td>0.006</td><td>0.022</td><td>0.386</td><td>190</td><td>tags=67%, list=25%, signal=87%</td></tr><tr><td class='lessen'>41</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>17</td><td>0.50</td><td>2.02</td><td>0.000</td><td>0.023</td><td>0.402</td><td>334</td><td>tags=94%, list=43%, signal=163%</td></tr><tr><td class='lessen'>42</td><td>MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP</td><td></td><td>23</td><td>0.46</td><td>2.01</td><td>0.003</td><td>0.023</td><td>0.414</td><td>155</td><td>tags=57%, list=20%, signal=69%</td></tr><tr><td class='lessen'>43</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP</td><td></td><td>36</td><td>0.37</td><td>2.01</td><td>0.004</td><td>0.023</td><td>0.416</td><td>136</td><td>tags=42%, list=18%, signal=48%</td></tr><tr><td class='lessen'>44</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN</td><td></td><td>33</td><td>0.41</td><td>2.01</td><td>0.000</td><td>0.022</td><td>0.418</td><td>310</td><td>tags=79%, list=40%, signal=126%</td></tr><tr><td class='lessen'>45</td><td>SANA_TNF_SIGNALING_DN</td><td></td><td>16</td><td>0.50</td><td>2.00</td><td>0.000</td><td>0.023</td><td>0.426</td><td>32</td><td>tags=31%, list=4%, signal=32%</td></tr><tr><td class='lessen'>46</td><td>GNATENKO_PLATELET_SIGNATURE</td><td></td><td>16</td><td>0.52</td><td>1.99</td><td>0.000</td><td>0.024</td><td>0.456</td><td>66</td><td>tags=38%, list=9%, signal=40%</td></tr><tr><td class='lessen'>47</td><td>ZHONG_SECRETOME_OF_LUNG_CANCER_AND_MACROPHAGE</td><td></td><td>21</td><td>0.47</td><td>1.99</td><td>0.000</td><td>0.025</td><td>0.472</td><td>123</td><td>tags=48%, list=16%, signal=55%</td></tr><tr><td class='lessen'>48</td><td>WP_VEGFAVEGFR2_SIGNALING_PATHWAY</td><td></td><td>48</td><td>0.36</td><td>1.99</td><td>0.000</td><td>0.024</td><td>0.475</td><td>294</td><td>tags=65%, list=38%, signal=98%</td></tr><tr><td class='lessen'>49</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_DN</td><td></td><td>29</td><td>0.42</td><td>1.98</td><td>0.000</td><td>0.026</td><td>0.502</td><td>196</td><td>tags=55%, list=25%, signal=71%</td></tr><tr><td class='lessen'>50</td><td>MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP</td><td></td><td>29</td><td>0.40</td><td>1.97</td><td>0.003</td><td>0.026</td><td>0.522</td><td>318</td><td>tags=76%, list=41%, signal=124%</td></tr><tr><td class='lessen'>51</td><td>HELLER_SILENCED_BY_METHYLATION_UP</td><td></td><td>19</td><td>0.48</td><td>1.96</td><td>0.000</td><td>0.029</td><td>0.560</td><td>72</td><td>tags=37%, list=9%, signal=40%</td></tr><tr><td class='lessen'>52</td><td>DELACROIX_RARG_BOUND_MEF</td><td></td><td>30</td><td>0.40</td><td>1.95</td><td>0.000</td><td>0.030</td><td>0.584</td><td>192</td><td>tags=53%, list=25%, signal=68%</td></tr><tr><td class='lessen'>53</td><td>REACTOME_CELL_CELL_COMMUNICATION</td><td></td><td>22</td><td>0.44</td><td>1.95</td><td>0.007</td><td>0.031</td><td>0.594</td><td>343</td><td>tags=86%, list=45%, signal=151%</td></tr><tr><td class='lessen'>54</td><td>REACTOME_CELL_JUNCTION_ORGANIZATION</td><td></td><td>21</td><td>0.45</td><td>1.93</td><td>0.006</td><td>0.035</td><td>0.647</td><td>269</td><td>tags=71%, list=35%, signal=107%</td></tr><tr><td class='lessen'>55</td><td>REACTOME_RHO_GTPASE_EFFECTORS</td><td></td><td>26</td><td>0.42</td><td>1.92</td><td>0.017</td><td>0.035</td><td>0.650</td><td>258</td><td>tags=69%, list=34%, signal=101%</td></tr><tr><td class='lessen'>56</td><td>REACTOME_SIGNALING_BY_RHO_GTPASES</td><td></td><td>27</td><td>0.41</td><td>1.92</td><td>0.011</td><td>0.035</td><td>0.655</td><td>258</td><td>tags=67%, list=34%, signal=97%</td></tr><tr><td class='lessen'>57</td><td>CHICAS_RB1_TARGETS_CONFLUENT</td><td></td><td>52</td><td>0.34</td><td>1.91</td><td>0.000</td><td>0.036</td><td>0.683</td><td>150</td><td>tags=37%, list=20%, signal=42%</td></tr><tr><td class='lessen'>58</td><td>GROSS_HYPOXIA_VIA_ELK3_AND_HIF1A_UP</td><td></td><td>16</td><td>0.49</td><td>1.90</td><td>0.003</td><td>0.040</td><td>0.728</td><td>111</td><td>tags=50%, list=14%, signal=57%</td></tr><tr><td class='lessen'>59</td><td>YAGI_AML_FAB_MARKERS</td><td></td><td>17</td><td>0.47</td><td>1.89</td><td>0.012</td><td>0.041</td><td>0.748</td><td>295</td><td>tags=82%, list=38%, signal=131%</td></tr><tr><td class='lessen'>60</td><td>WANG_CISPLATIN_RESPONSE_AND_XPC_UP</td><td></td><td>15</td><td>0.48</td><td>1.89</td><td>0.008</td><td>0.041</td><td>0.754</td><td>148</td><td>tags=53%, list=19%, signal=65%</td></tr><tr><td class='lessen'>61</td><td>KEGG_REGULATION_OF_ACTIN_CYTOSKELETON</td><td></td><td>18</td><td>0.46</td><td>1.88</td><td>0.008</td><td>0.044</td><td>0.778</td><td>336</td><td>tags=89%, list=44%, signal=154%</td></tr><tr><td class='lessen'>62</td><td>VANTVEER_BREAST_CANCER_ESR1_DN</td><td></td><td>18</td><td>0.46</td><td>1.87</td><td>0.014</td><td>0.045</td><td>0.789</td><td>312</td><td>tags=89%, list=41%, signal=146%</td></tr><tr><td class='lessen'>63</td><td>FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP</td><td></td><td>21</td><td>0.43</td><td>1.85</td><td>0.000</td><td>0.051</td><td>0.838</td><td>68</td><td>tags=33%, list=9%, signal=36%</td></tr><tr><td class='lessen'>64</td><td>ONDER_CDH1_TARGETS_2_DN</td><td></td><td>59</td><td>0.32</td><td>1.85</td><td>0.000</td><td>0.051</td><td>0.843</td><td>148</td><td>tags=39%, list=19%, signal=45%</td></tr><tr><td class='lessen'>65</td><td>REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION</td><td></td><td>21</td><td>0.43</td><td>1.84</td><td>0.009</td><td>0.051</td><td>0.845</td><td>319</td><td>tags=90%, list=41%, signal=150%</td></tr><tr><td class='lessen'>66</td><td>ELVIDGE_HYPOXIA_UP</td><td></td><td>26</td><td>0.40</td><td>1.84</td><td>0.007</td><td>0.052</td><td>0.854</td><td>67</td><td>tags=31%, list=9%, signal=33%</td></tr><tr><td class='lessen'>67</td><td>LU_EZH2_TARGETS_UP</td><td></td><td>29</td><td>0.38</td><td>1.83</td><td>0.010</td><td>0.054</td><td>0.866</td><td>111</td><td>tags=34%, list=14%, signal=39%</td></tr><tr><td class='lessen'>68</td><td>LU_EZH2_TARGETS_DN</td><td></td><td>19</td><td>0.43</td><td>1.83</td><td>0.009</td><td>0.054</td><td>0.870</td><td>355</td><td>tags=89%, list=46%, signal=162%</td></tr><tr><td class='lessen'>69</td><td>BASAKI_YBX1_TARGETS_UP</td><td></td><td>26</td><td>0.40</td><td>1.83</td><td>0.007</td><td>0.054</td><td>0.876</td><td>110</td><td>tags=38%, list=14%, signal=43%</td></tr><tr><td class='lessen'>70</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN</td><td></td><td>38</td><td>0.36</td><td>1.82</td><td>0.011</td><td>0.053</td><td>0.877</td><td>325</td><td>tags=76%, list=42%, signal=126%</td></tr><tr><td class='lessen'>71</td><td>REACTOME_RRNA_PROCESSING</td><td></td><td>39</td><td>0.36</td><td>1.82</td><td>0.008</td><td>0.053</td><td>0.877</td><td>49</td><td>tags=26%, list=6%, signal=26%</td></tr><tr><td class='lessen'>72</td><td>KEGG_RIBOSOME</td><td></td><td>36</td><td>0.35</td><td>1.82</td><td>0.004</td><td>0.052</td><td>0.877</td><td>49</td><td>tags=25%, list=6%, signal=25%</td></tr><tr><td class='lessen'>73</td><td>REACTOME_NONSENSE_MEDIATED_DECAY_NMD_</td><td></td><td>36</td><td>0.35</td><td>1.82</td><td>0.004</td><td>0.052</td><td>0.881</td><td>49</td><td>tags=25%, list=6%, signal=25%</td></tr><tr><td class='lessen'>74</td><td>WP_CYTOPLASMIC_RIBOSOMAL_PROTEINS</td><td></td><td>34</td><td>0.37</td><td>1.82</td><td>0.022</td><td>0.052</td><td>0.885</td><td>49</td><td>tags=26%, list=6%, signal=27%</td></tr><tr><td class='lessen'>75</td><td>WU_CELL_MIGRATION</td><td></td><td>26</td><td>0.39</td><td>1.82</td><td>0.010</td><td>0.052</td><td>0.891</td><td>82</td><td>tags=35%, list=11%, signal=37%</td></tr><tr><td class='lessen'>76</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP</td><td></td><td>16</td><td>0.47</td><td>1.82</td><td>0.017</td><td>0.052</td><td>0.894</td><td>324</td><td>tags=88%, list=42%, signal=148%</td></tr><tr><td class='lessen'>77</td><td>MATSUDA_NATURAL_KILLER_DIFFERENTIATION</td><td></td><td>48</td><td>0.33</td><td>1.81</td><td>0.004</td><td>0.053</td><td>0.903</td><td>174</td><td>tags=46%, list=23%, signal=56%</td></tr><tr><td class='lessen'>78</td><td>FOURNIER_ACINAR_DEVELOPMENT_LATE_2</td><td></td><td>31</td><td>0.36</td><td>1.81</td><td>0.007</td><td>0.052</td><td>0.904</td><td>121</td><td>tags=39%, list=16%, signal=44%</td></tr><tr><td class='lessen'>79</td><td>JINESH_BLEBBISHIELD_TO_IMMUNE_CELL_FUSION_PBSHMS_UP</td><td></td><td>46</td><td>0.32</td><td>1.80</td><td>0.005</td><td>0.056</td><td>0.917</td><td>85</td><td>tags=30%, list=11%, signal=32%</td></tr><tr><td class='lessen'>80</td><td>REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY</td><td></td><td>38</td><td>0.35</td><td>1.80</td><td>0.000</td><td>0.055</td><td>0.920</td><td>219</td><td>tags=53%, list=28%, signal=70%</td></tr><tr><td class='lessen'>81</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_DN</td><td></td><td>88</td><td>0.27</td><td>1.80</td><td>0.007</td><td>0.055</td><td>0.920</td><td>329</td><td>tags=65%, list=43%, signal=100%</td></tr><tr><td class='lessen'>82</td><td>QI_PLASMACYTOMA_UP</td><td></td><td>25</td><td>0.39</td><td>1.79</td><td>0.013</td><td>0.057</td><td>0.927</td><td>155</td><td>tags=48%, list=20%, signal=58%</td></tr><tr><td class='lessen'>83</td><td>ZWANG_CLASS_3_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>21</td><td>0.41</td><td>1.78</td><td>0.000</td><td>0.062</td><td>0.945</td><td>241</td><td>tags=67%, list=31%, signal=94%</td></tr><tr><td class='lessen'>84</td><td>REACTOME_EUKARYOTIC_TRANSLATION_ELONGATION</td><td></td><td>38</td><td>0.33</td><td>1.78</td><td>0.012</td><td>0.061</td><td>0.945</td><td>49</td><td>tags=24%, list=6%, signal=24%</td></tr><tr><td class='lessen'>85</td><td>KEGG_LEUKOCYTE_TRANSENDOTHELIAL_MIGRATION</td><td></td><td>18</td><td>0.43</td><td>1.77</td><td>0.022</td><td>0.062</td><td>0.953</td><td>269</td><td>tags=72%, list=35%, signal=108%</td></tr><tr><td class='lessen'>86</td><td>IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP</td><td></td><td>15</td><td>0.46</td><td>1.77</td><td>0.015</td><td>0.062</td><td>0.954</td><td>155</td><td>tags=67%, list=20%, signal=82%</td></tr><tr><td class='lessen'>87</td><td>LI_AMPLIFIED_IN_LUNG_CANCER</td><td></td><td>42</td><td>0.33</td><td>1.74</td><td>0.008</td><td>0.072</td><td>0.972</td><td>164</td><td>tags=52%, list=21%, signal=63%</td></tr><tr><td class='lessen'>88</td><td>MOHANKUMAR_HOXA1_TARGETS_DN</td><td></td><td>19</td><td>0.42</td><td>1.74</td><td>0.019</td><td>0.071</td><td>0.972</td><td>69</td><td>tags=42%, list=9%, signal=45%</td></tr><tr><td class='lessen'>89</td><td>REACTOME_SELENOAMINO_ACID_METABOLISM</td><td></td><td>37</td><td>0.34</td><td>1.73</td><td>0.004</td><td>0.075</td><td>0.980</td><td>219</td><td>tags=51%, list=28%, signal=68%</td></tr><tr><td class='lessen'>90</td><td>DAZARD_RESPONSE_TO_UV_SCC_UP</td><td></td><td>17</td><td>0.43</td><td>1.73</td><td>0.032</td><td>0.077</td><td>0.981</td><td>134</td><td>tags=53%, list=17%, signal=63%</td></tr><tr><td class='lessen'>91</td><td>GALINDO_IMMUNE_RESPONSE_TO_ENTEROTOXIN</td><td></td><td>15</td><td>0.45</td><td>1.72</td><td>0.013</td><td>0.077</td><td>0.982</td><td>155</td><td>tags=60%, list=20%, signal=74%</td></tr><tr><td class='lessen'>92</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_UP</td><td></td><td>63</td><td>0.28</td><td>1.72</td><td>0.011</td><td>0.078</td><td>0.983</td><td>240</td><td>tags=56%, list=31%, signal=74%</td></tr><tr><td class='lessen'>93</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13</td><td></td><td>39</td><td>0.34</td><td>1.72</td><td>0.031</td><td>0.080</td><td>0.985</td><td>131</td><td>tags=33%, list=17%, signal=38%</td></tr><tr><td class='lessen'>94</td><td>LIU_PROSTATE_CANCER_DN</td><td></td><td>32</td><td>0.35</td><td>1.71</td><td>0.007</td><td>0.081</td><td>0.985</td><td>89</td><td>tags=31%, list=12%, signal=34%</td></tr><tr><td class='lessen'>95</td><td>HOEBEKE_LYMPHOID_STEM_CELL_DN</td><td></td><td>16</td><td>0.42</td><td>1.70</td><td>0.036</td><td>0.088</td><td>0.988</td><td>169</td><td>tags=44%, list=22%, signal=55%</td></tr><tr><td class='lessen'>96</td><td>REACTOME_INFLUENZA_INFECTION</td><td></td><td>40</td><td>0.32</td><td>1.70</td><td>0.032</td><td>0.087</td><td>0.989</td><td>49</td><td>tags=23%, list=6%, signal=23%</td></tr><tr><td class='lessen'>97</td><td>GENTILE_UV_HIGH_DOSE_DN</td><td></td><td>18</td><td>0.41</td><td>1.69</td><td>0.028</td><td>0.090</td><td>0.990</td><td>325</td><td>tags=83%, list=42%, signal=141%</td></tr><tr><td class='lessen'>98</td><td>GOLDRATH_ANTIGEN_RESPONSE</td><td></td><td>50</td><td>0.29</td><td>1.69</td><td>0.009</td><td>0.089</td><td>0.990</td><td>68</td><td>tags=22%, list=9%, signal=23%</td></tr><tr><td class='lessen'>99</td><td>RASHI_RESPONSE_TO_IONIZING_RADIATION_2</td><td></td><td>18</td><td>0.41</td><td>1.69</td><td>0.033</td><td>0.090</td><td>0.993</td><td>196</td><td>tags=50%, list=25%, signal=66%</td></tr><tr><td class='lessen'>100</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_DN</td><td></td><td>20</td><td>0.40</td><td>1.68</td><td>0.029</td><td>0.095</td><td>0.995</td><td>110</td><td>tags=35%, list=14%, signal=40%</td></tr><tr><td class='lessen'>101</td><td>REACTOME_CELLULAR_RESPONSES_TO_EXTERNAL_STIMULI</td><td></td><td>79</td><td>0.27</td><td>1.67</td><td>0.000</td><td>0.096</td><td>0.995</td><td>154</td><td>tags=35%, list=20%, signal=40%</td></tr><tr><td class='lessen'>102</td><td>CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN</td><td></td><td>48</td><td>0.30</td><td>1.67</td><td>0.000</td><td>0.097</td><td>0.995</td><td>238</td><td>tags=54%, list=31%, signal=74%</td></tr><tr><td class='lessen'>103</td><td>REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES</td><td></td><td>35</td><td>0.34</td><td>1.66</td><td>0.030</td><td>0.098</td><td>0.995</td><td>293</td><td>tags=66%, list=38%, signal=101%</td></tr><tr><td class='lessen'>104</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN</td><td></td><td>15</td><td>0.45</td><td>1.66</td><td>0.039</td><td>0.099</td><td>0.995</td><td>329</td><td>tags=87%, list=43%, signal=149%</td></tr><tr><td class='lessen'>105</td><td>MITSIADES_RESPONSE_TO_APLIDIN_DN</td><td></td><td>17</td><td>0.42</td><td>1.66</td><td>0.038</td><td>0.098</td><td>0.995</td><td>336</td><td>tags=88%, list=44%, signal=153%</td></tr><tr><td class='lessen'>106</td><td>WANG_TUMOR_INVASIVENESS_UP</td><td></td><td>65</td><td>0.27</td><td>1.66</td><td>0.009</td><td>0.098</td><td>0.995</td><td>235</td><td>tags=46%, list=31%, signal=61%</td></tr><tr><td class='lessen'>107</td><td>VERHAAK_GLIOBLASTOMA_MESENCHYMAL</td><td></td><td>23</td><td>0.38</td><td>1.66</td><td>0.027</td><td>0.098</td><td>0.997</td><td>59</td><td>tags=22%, list=8%, signal=23%</td></tr><tr><td class='lessen'>108</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>53</td><td>0.28</td><td>1.65</td><td>0.013</td><td>0.099</td><td>0.997</td><td>278</td><td>tags=57%, list=36%, signal=83%</td></tr><tr><td class='lessen'>109</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP</td><td></td><td>30</td><td>0.33</td><td>1.64</td><td>0.029</td><td>0.106</td><td>0.998</td><td>69</td><td>tags=27%, list=9%, signal=28%</td></tr><tr><td class='lessen'>110</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>23</td><td>0.36</td><td>1.62</td><td>0.054</td><td>0.118</td><td>0.999</td><td>204</td><td>tags=61%, list=27%, signal=80%</td></tr><tr><td class='lessen'>111</td><td>SWEET_LUNG_CANCER_KRAS_UP</td><td></td><td>94</td><td>0.25</td><td>1.62</td><td>0.000</td><td>0.117</td><td>0.999</td><td>158</td><td>tags=36%, list=21%, signal=40%</td></tr><tr><td class='lessen'>112</td><td>WONG_ADULT_TISSUE_STEM_MODULE</td><td></td><td>64</td><td>0.27</td><td>1.61</td><td>0.026</td><td>0.122</td><td>0.999</td><td>220</td><td>tags=44%, list=29%, signal=56%</td></tr><tr><td class='lessen'>113</td><td>FISCHER_DREAM_TARGETS</td><td></td><td>28</td><td>0.34</td><td>1.61</td><td>0.039</td><td>0.122</td><td>0.999</td><td>234</td><td>tags=61%, list=30%, signal=84%</td></tr><tr><td class='lessen'>114</td><td>KEGG_PATHWAYS_IN_CANCER</td><td></td><td>21</td><td>0.37</td><td>1.61</td><td>0.035</td><td>0.122</td><td>0.999</td><td>324</td><td>tags=76%, list=42%, signal=128%</td></tr><tr><td class='lessen'>115</td><td>HSIAO_HOUSEKEEPING_GENES</td><td></td><td>112</td><td>0.23</td><td>1.60</td><td>0.016</td><td>0.121</td><td>0.999</td><td>49</td><td>tags=15%, list=6%, signal=14%</td></tr><tr><td class='lessen'>116</td><td>ONKEN_UVEAL_MELANOMA_UP</td><td></td><td>62</td><td>0.27</td><td>1.60</td><td>0.015</td><td>0.126</td><td>1.000</td><td>142</td><td>tags=31%, list=18%, signal=35%</td></tr><tr><td class='lessen'>117</td><td>DOANE_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>15</td><td>0.42</td><td>1.60</td><td>0.045</td><td>0.125</td><td>1.000</td><td>68</td><td>tags=33%, list=9%, signal=36%</td></tr><tr><td class='lessen'>118</td><td>REACTOME_EUKARYOTIC_TRANSLATION_INITIATION</td><td></td><td>45</td><td>0.29</td><td>1.59</td><td>0.020</td><td>0.129</td><td>1.000</td><td>219</td><td>tags=47%, list=28%, signal=61%</td></tr><tr><td class='lessen'>119</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_UP</td><td></td><td>23</td><td>0.36</td><td>1.59</td><td>0.052</td><td>0.129</td><td>1.000</td><td>122</td><td>tags=43%, list=16%, signal=50%</td></tr><tr><td class='lessen'>120</td><td>ANDERSEN_CHOLANGIOCARCINOMA_CLASS2</td><td></td><td>28</td><td>0.34</td><td>1.59</td><td>0.017</td><td>0.128</td><td>1.000</td><td>141</td><td>tags=43%, list=18%, signal=51%</td></tr><tr><td class='lessen'>121</td><td>JOHNSTONE_PARVB_TARGETS_3_UP</td><td></td><td>54</td><td>0.28</td><td>1.58</td><td>0.040</td><td>0.130</td><td>1.000</td><td>164</td><td>tags=35%, list=21%, signal=42%</td></tr><tr><td class='lessen'>122</td><td>REACTOME_DEVELOPMENTAL_BIOLOGY</td><td></td><td>92</td><td>0.25</td><td>1.58</td><td>0.000</td><td>0.130</td><td>1.000</td><td>302</td><td>tags=59%, list=39%, signal=85%</td></tr><tr><td class='lessen'>123</td><td>DESERT_STEM_CELL_HEPATOCELLULAR_CARCINOMA_SUBCLASS_UP</td><td></td><td>31</td><td>0.33</td><td>1.58</td><td>0.046</td><td>0.130</td><td>1.000</td><td>173</td><td>tags=42%, list=22%, signal=52%</td></tr><tr><td class='lessen'>124</td><td>BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP</td><td></td><td>39</td><td>0.30</td><td>1.58</td><td>0.061</td><td>0.131</td><td>1.000</td><td>339</td><td>tags=67%, list=44%, signal=113%</td></tr><tr><td class='lessen'>125</td><td>REACTOME_SRP_DEPENDENT_COTRANSLATIONAL_PROTEIN_TARGETING_TO_MEMBRANE</td><td></td><td>43</td><td>0.29</td><td>1.57</td><td>0.037</td><td>0.136</td><td>1.000</td><td>49</td><td>tags=21%, list=6%, signal=21%</td></tr><tr><td class='lessen'>126</td><td>GOZGIT_ESR1_TARGETS_DN</td><td></td><td>53</td><td>0.27</td><td>1.57</td><td>0.019</td><td>0.136</td><td>1.000</td><td>65</td><td>tags=23%, list=8%, signal=23%</td></tr><tr><td class='lessen'>127</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_UP</td><td></td><td>20</td><td>0.38</td><td>1.56</td><td>0.044</td><td>0.136</td><td>1.000</td><td>90</td><td>tags=35%, list=12%, signal=39%</td></tr><tr><td class='lessen'>128</td><td>GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_UP</td><td></td><td>43</td><td>0.29</td><td>1.56</td><td>0.017</td><td>0.136</td><td>1.000</td><td>164</td><td>tags=37%, list=21%, signal=45%</td></tr><tr><td class='lessen'>129</td><td>DAZARD_RESPONSE_TO_UV_NHEK_UP</td><td></td><td>38</td><td>0.29</td><td>1.55</td><td>0.029</td><td>0.141</td><td>1.000</td><td>189</td><td>tags=45%, list=25%, signal=56%</td></tr><tr><td class='lessen'>130</td><td>BROWN_MYELOID_CELL_DEVELOPMENT_UP</td><td></td><td>27</td><td>0.33</td><td>1.55</td><td>0.056</td><td>0.143</td><td>1.000</td><td>121</td><td>tags=37%, list=16%, signal=42%</td></tr><tr><td class='lessen'>131</td><td>ICHIBA_GRAFT_VERSUS_HOST_DISEASE_35D_UP</td><td></td><td>24</td><td>0.35</td><td>1.55</td><td>0.054</td><td>0.142</td><td>1.000</td><td>33</td><td>tags=29%, list=4%, signal=30%</td></tr><tr><td class='lessen'>132</td><td>REACTOME_HEMOSTASIS</td><td></td><td>41</td><td>0.29</td><td>1.54</td><td>0.025</td><td>0.145</td><td>1.000</td><td>144</td><td>tags=41%, list=19%, signal=48%</td></tr><tr><td class='lessen'>133</td><td>NAGASHIMA_NRG1_SIGNALING_UP</td><td></td><td>22</td><td>0.36</td><td>1.54</td><td>0.032</td><td>0.145</td><td>1.000</td><td>274</td><td>tags=68%, list=36%, signal=103%</td></tr><tr><td class='lessen'>134</td><td>LANDIS_ERBB2_BREAST_TUMORS_324_UP</td><td></td><td>22</td><td>0.35</td><td>1.54</td><td>0.069</td><td>0.146</td><td>1.000</td><td>318</td><td>tags=73%, list=41%, signal=120%</td></tr><tr><td class='lessen'>135</td><td>HUTTMANN_B_CLL_POOR_SURVIVAL_UP</td><td></td><td>18</td><td>0.37</td><td>1.53</td><td>0.094</td><td>0.153</td><td>1.000</td><td>51</td><td>tags=22%, list=7%, signal=23%</td></tr><tr><td class='lessen'>136</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_UP</td><td></td><td>27</td><td>0.32</td><td>1.53</td><td>0.049</td><td>0.155</td><td>1.000</td><td>276</td><td>tags=70%, list=36%, signal=106%</td></tr><tr><td class='lessen'>137</td><td>MARTINEZ_RB1_AND_TP53_TARGETS_DN</td><td></td><td>55</td><td>0.26</td><td>1.51</td><td>0.023</td><td>0.162</td><td>1.000</td><td>247</td><td>tags=49%, list=32%, signal=67%</td></tr><tr><td class='lessen'>138</td><td>PROVENZANI_METASTASIS_DN</td><td></td><td>17</td><td>0.37</td><td>1.50</td><td>0.066</td><td>0.174</td><td>1.000</td><td>69</td><td>tags=24%, list=9%, signal=25%</td></tr><tr><td class='lessen'>139</td><td>OSMAN_BLADDER_CANCER_UP</td><td></td><td>22</td><td>0.35</td><td>1.50</td><td>0.074</td><td>0.176</td><td>1.000</td><td>234</td><td>tags=59%, list=30%, signal=83%</td></tr><tr><td class='lessen'>140</td><td>KEGG_TIGHT_JUNCTION</td><td></td><td>17</td><td>0.37</td><td>1.49</td><td>0.090</td><td>0.183</td><td>1.000</td><td>343</td><td>tags=82%, list=45%, signal=145%</td></tr><tr><td class='lessen'>141</td><td>HIRSCH_CELLULAR_TRANSFORMATION_SIGNATURE_UP</td><td></td><td>22</td><td>0.35</td><td>1.48</td><td>0.091</td><td>0.183</td><td>1.000</td><td>188</td><td>tags=50%, list=24%, signal=64%</td></tr><tr><td class='lessen'>142</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_UP</td><td></td><td>32</td><td>0.30</td><td>1.48</td><td>0.069</td><td>0.188</td><td>1.000</td><td>250</td><td>tags=53%, list=33%, signal=75%</td></tr><tr><td class='lessen'>143</td><td>SENESE_HDAC1_TARGETS_UP</td><td></td><td>27</td><td>0.31</td><td>1.48</td><td>0.104</td><td>0.189</td><td>1.000</td><td>336</td><td>tags=78%, list=44%, signal=133%</td></tr><tr><td class='lessen'>144</td><td>JAEGER_METASTASIS_DN</td><td></td><td>31</td><td>0.31</td><td>1.47</td><td>0.081</td><td>0.189</td><td>1.000</td><td>164</td><td>tags=48%, list=21%, signal=59%</td></tr><tr><td class='lessen'>145</td><td>BENPORATH_MYC_MAX_TARGETS</td><td></td><td>72</td><td>0.24</td><td>1.47</td><td>0.028</td><td>0.188</td><td>1.000</td><td>219</td><td>tags=44%, list=28%, signal=56%</td></tr><tr><td class='lessen'>146</td><td>SESTO_RESPONSE_TO_UV_C0</td><td></td><td>16</td><td>0.38</td><td>1.47</td><td>0.079</td><td>0.189</td><td>1.000</td><td>46</td><td>tags=25%, list=6%, signal=26%</td></tr><tr><td class='lessen'>147</td><td>OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP</td><td></td><td>20</td><td>0.35</td><td>1.46</td><td>0.088</td><td>0.198</td><td>1.000</td><td>60</td><td>tags=25%, list=8%, signal=26%</td></tr><tr><td class='lessen'>148</td><td>BLANCO_MELO_BETA_INTERFERON_TREATED_BRONCHIAL_EPITHELIAL_CELLS_UP</td><td></td><td>17</td><td>0.37</td><td>1.45</td><td>0.073</td><td>0.202</td><td>1.000</td><td>196</td><td>tags=65%, list=25%, signal=85%</td></tr><tr><td class='lessen'>149</td><td>BENPORATH_SOX2_TARGETS</td><td></td><td>46</td><td>0.26</td><td>1.45</td><td>0.054</td><td>0.201</td><td>1.000</td><td>254</td><td>tags=50%, list=33%, signal=70%</td></tr><tr><td class='lessen'>150</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP</td><td></td><td>36</td><td>0.28</td><td>1.44</td><td>0.073</td><td>0.210</td><td>1.000</td><td>245</td><td>tags=50%, list=32%, signal=70%</td></tr><tr><td class='lessen'>151</td><td>REACTOME_PROGRAMMED_CELL_DEATH</td><td></td><td>27</td><td>0.31</td><td>1.44</td><td>0.069</td><td>0.208</td><td>1.000</td><td>139</td><td>tags=41%, list=18%, signal=48%</td></tr><tr><td class='lessen'>152</td><td>REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM</td><td></td><td>65</td><td>0.24</td><td>1.44</td><td>0.050</td><td>0.207</td><td>1.000</td><td>129</td><td>tags=29%, list=17%, signal=32%</td></tr><tr><td class='lessen'>153</td><td>GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS</td><td></td><td>51</td><td>0.25</td><td>1.44</td><td>0.069</td><td>0.206</td><td>1.000</td><td>308</td><td>tags=65%, list=40%, signal=101%</td></tr><tr><td class='lessen'>154</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_DN</td><td></td><td>57</td><td>0.24</td><td>1.44</td><td>0.053</td><td>0.210</td><td>1.000</td><td>228</td><td>tags=47%, list=30%, signal=62%</td></tr><tr><td class='lessen'>155</td><td>QI_HYPOXIA</td><td></td><td>15</td><td>0.37</td><td>1.44</td><td>0.091</td><td>0.209</td><td>1.000</td><td>318</td><td>tags=80%, list=41%, signal=134%</td></tr><tr><td class='lessen'>156</td><td>DUTERTRE_ESTRADIOL_RESPONSE_24HR_DN</td><td></td><td>40</td><td>0.27</td><td>1.43</td><td>0.080</td><td>0.210</td><td>1.000</td><td>341</td><td>tags=70%, list=44%, signal=119%</td></tr><tr><td class='lessen'>157</td><td>MARSON_BOUND_BY_FOXP3_STIMULATED</td><td></td><td>56</td><td>0.25</td><td>1.43</td><td>0.063</td><td>0.210</td><td>1.000</td><td>224</td><td>tags=45%, list=29%, signal=58%</td></tr><tr><td class='lessen'>158</td><td>DANG_BOUND_BY_MYC</td><td></td><td>90</td><td>0.22</td><td>1.43</td><td>0.061</td><td>0.213</td><td>1.000</td><td>243</td><td>tags=48%, list=32%, signal=62%</td></tr><tr><td class='lessen'>159</td><td>PEDRIOLI_MIR31_TARGETS_DN</td><td></td><td>18</td><td>0.36</td><td>1.43</td><td>0.096</td><td>0.215</td><td>1.000</td><td>74</td><td>tags=28%, list=10%, signal=30%</td></tr><tr><td class='lessen'>160</td><td>ELVIDGE_HYPOXIA_BY_DMOG_UP</td><td></td><td>22</td><td>0.32</td><td>1.42</td><td>0.096</td><td>0.217</td><td>1.000</td><td>121</td><td>tags=32%, list=16%, signal=37%</td></tr><tr><td class='lessen'>161</td><td>SENESE_HDAC1_AND_HDAC2_TARGETS_DN</td><td></td><td>19</td><td>0.34</td><td>1.42</td><td>0.110</td><td>0.219</td><td>1.000</td><td>19</td><td>tags=16%, list=2%, signal=16%</td></tr><tr><td class='lessen'>162</td><td>KIM_RESPONSE_TO_TSA_AND_DECITABINE_UP</td><td></td><td>16</td><td>0.37</td><td>1.41</td><td>0.107</td><td>0.223</td><td>1.000</td><td>195</td><td>tags=50%, list=25%, signal=66%</td></tr><tr><td class='lessen'>163</td><td>LEI_MYB_TARGETS</td><td></td><td>52</td><td>0.25</td><td>1.41</td><td>0.046</td><td>0.227</td><td>1.000</td><td>172</td><td>tags=44%, list=22%, signal=53%</td></tr><tr><td class='lessen'>164</td><td>HAN_SATB1_TARGETS_DN</td><td></td><td>31</td><td>0.28</td><td>1.41</td><td>0.093</td><td>0.226</td><td>1.000</td><td>69</td><td>tags=26%, list=9%, signal=27%</td></tr><tr><td class='lessen'>165</td><td>TIEN_INTESTINE_PROBIOTICS_6HR_UP</td><td></td><td>17</td><td>0.35</td><td>1.41</td><td>0.100</td><td>0.225</td><td>1.000</td><td>49</td><td>tags=24%, list=6%, signal=25%</td></tr><tr><td class='lessen'>166</td><td>CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN</td><td></td><td>18</td><td>0.36</td><td>1.41</td><td>0.100</td><td>0.227</td><td>1.000</td><td>142</td><td>tags=50%, list=18%, signal=60%</td></tr><tr><td class='lessen'>167</td><td>CHYLA_CBFA2T3_TARGETS_UP</td><td></td><td>29</td><td>0.29</td><td>1.40</td><td>0.075</td><td>0.227</td><td>1.000</td><td>115</td><td>tags=31%, list=15%, signal=35%</td></tr><tr><td class='lessen'>168</td><td>REACTOME_SIGNALING_BY_INTERLEUKINS</td><td></td><td>38</td><td>0.27</td><td>1.40</td><td>0.083</td><td>0.234</td><td>1.000</td><td>129</td><td>tags=34%, list=17%, signal=39%</td></tr><tr><td class='lessen'>169</td><td>RIGGINS_TAMOXIFEN_RESISTANCE_DN</td><td></td><td>17</td><td>0.34</td><td>1.39</td><td>0.116</td><td>0.235</td><td>1.000</td><td>293</td><td>tags=71%, list=38%, signal=112%</td></tr><tr><td class='lessen'>170</td><td>DODD_NASOPHARYNGEAL_CARCINOMA_UP</td><td></td><td>94</td><td>0.22</td><td>1.39</td><td>0.038</td><td>0.234</td><td>1.000</td><td>107</td><td>tags=24%, list=14%, signal=25%</td></tr><tr><td class='lessen'>171</td><td>GRYDER_PAX3FOXO1_ENHANCERS_KO_DOWN</td><td></td><td>23</td><td>0.31</td><td>1.38</td><td>0.114</td><td>0.243</td><td>1.000</td><td>308</td><td>tags=74%, list=40%, signal=120%</td></tr><tr><td class='lessen'>172</td><td>SERVITJA_ISLET_HNF1A_TARGETS_UP</td><td></td><td>18</td><td>0.34</td><td>1.38</td><td>0.114</td><td>0.242</td><td>1.000</td><td>37</td><td>tags=33%, list=5%, signal=34%</td></tr><tr><td class='lessen'>173</td><td>REACTOME_REGULATION_OF_EXPRESSION_OF_SLITS_AND_ROBOS</td><td></td><td>50</td><td>0.24</td><td>1.38</td><td>0.076</td><td>0.243</td><td>1.000</td><td>49</td><td>tags=18%, list=6%, signal=18%</td></tr><tr><td class='lessen'>174</td><td>BORLAK_LIVER_CANCER_EGF_UP</td><td></td><td>15</td><td>0.36</td><td>1.38</td><td>0.138</td><td>0.245</td><td>1.000</td><td>28</td><td>tags=27%, list=4%, signal=27%</td></tr><tr><td class='lessen'>175</td><td>WP_FOCAL_ADHESIONPI3KAKTMTORSIGNALING_PATHWAY</td><td></td><td>18</td><td>0.35</td><td>1.38</td><td>0.153</td><td>0.247</td><td>1.000</td><td>381</td><td>tags=83%, list=50%, signal=161%</td></tr><tr><td class='lessen'>176</td><td>MEISSNER_NPC_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>32</td><td>0.28</td><td>1.38</td><td>0.138</td><td>0.247</td><td>1.000</td><td>148</td><td>tags=38%, list=19%, signal=45%</td></tr><tr><td class='lessen'>177</td><td>MULLIGHAN_MLL_SIGNATURE_2_UP</td><td></td><td>28</td><td>0.29</td><td>1.37</td><td>0.117</td><td>0.246</td><td>1.000</td><td>140</td><td>tags=32%, list=18%, signal=38%</td></tr><tr><td class='lessen'>178</td><td>SARRIO_EPITHELIAL_MESENCHYMAL_TRANSITION_DN</td><td></td><td>26</td><td>0.30</td><td>1.37</td><td>0.135</td><td>0.247</td><td>1.000</td><td>72</td><td>tags=27%, list=9%, signal=29%</td></tr><tr><td class='lessen'>179</td><td>GRADE_COLON_AND_RECTAL_CANCER_UP</td><td></td><td>20</td><td>0.33</td><td>1.37</td><td>0.118</td><td>0.247</td><td>1.000</td><td>223</td><td>tags=55%, list=29%, signal=75%</td></tr><tr><td class='lessen'>180</td><td>VERHAAK_AML_WITH_NPM1_MUTATED_UP</td><td></td><td>25</td><td>0.30</td><td>1.37</td><td>0.117</td><td>0.251</td><td>1.000</td><td>142</td><td>tags=40%, list=18%, signal=47%</td></tr><tr><td class='lessen'>181</td><td>MARTINEZ_RB1_TARGETS_DN</td><td></td><td>55</td><td>0.24</td><td>1.37</td><td>0.090</td><td>0.250</td><td>1.000</td><td>187</td><td>tags=36%, list=24%, signal=45%</td></tr><tr><td class='lessen'>182</td><td>REACTOME_SIGNALING_BY_ROBO_RECEPTORS</td><td></td><td>50</td><td>0.24</td><td>1.37</td><td>0.116</td><td>0.250</td><td>1.000</td><td>49</td><td>tags=18%, list=6%, signal=18%</td></tr><tr><td class='lessen'>183</td><td>SMID_BREAST_CANCER_LUMINAL_B_DN</td><td></td><td>41</td><td>0.26</td><td>1.37</td><td>0.102</td><td>0.249</td><td>1.000</td><td>110</td><td>tags=32%, list=14%, signal=35%</td></tr><tr><td class='lessen'>184</td><td>NELSON_RESPONSE_TO_ANDROGEN_UP</td><td></td><td>22</td><td>0.31</td><td>1.36</td><td>0.131</td><td>0.253</td><td>1.000</td><td>187</td><td>tags=55%, list=24%, signal=70%</td></tr><tr><td class='lessen'>185</td><td>REACTOME_METABOLISM_OF_RNA</td><td></td><td>70</td><td>0.23</td><td>1.36</td><td>0.072</td><td>0.255</td><td>1.000</td><td>228</td><td>tags=43%, list=30%, signal=55%</td></tr><tr><td class='lessen'>186</td><td>CUI_TCF21_TARGETS_2_UP</td><td></td><td>35</td><td>0.27</td><td>1.35</td><td>0.095</td><td>0.260</td><td>1.000</td><td>118</td><td>tags=29%, list=15%, signal=32%</td></tr><tr><td class='lessen'>187</td><td>SANSOM_APC_TARGETS_UP</td><td></td><td>15</td><td>0.35</td><td>1.35</td><td>0.149</td><td>0.264</td><td>1.000</td><td>307</td><td>tags=73%, list=40%, signal=120%</td></tr><tr><td class='lessen'>188</td><td>HUMMERICH_SKIN_CANCER_PROGRESSION_UP</td><td></td><td>20</td><td>0.31</td><td>1.34</td><td>0.101</td><td>0.265</td><td>1.000</td><td>141</td><td>tags=40%, list=18%, signal=48%</td></tr><tr><td class='lessen'>189</td><td>VECCHI_GASTRIC_CANCER_EARLY_UP</td><td></td><td>42</td><td>0.26</td><td>1.34</td><td>0.120</td><td>0.266</td><td>1.000</td><td>224</td><td>tags=45%, list=29%, signal=60%</td></tr><tr><td class='lessen'>190</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_DN</td><td></td><td>23</td><td>0.30</td><td>1.34</td><td>0.150</td><td>0.267</td><td>1.000</td><td>78</td><td>tags=26%, list=10%, signal=28%</td></tr><tr><td class='lessen'>191</td><td>ALFANO_MYC_TARGETS</td><td></td><td>26</td><td>0.29</td><td>1.33</td><td>0.132</td><td>0.280</td><td>1.000</td><td>139</td><td>tags=35%, list=18%, signal=41%</td></tr><tr><td class='lessen'>192</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_DN</td><td></td><td>20</td><td>0.30</td><td>1.33</td><td>0.177</td><td>0.280</td><td>1.000</td><td>49</td><td>tags=20%, list=6%, signal=21%</td></tr><tr><td class='lessen'>193</td><td>NUYTTEN_NIPP1_TARGETS_UP</td><td></td><td>32</td><td>0.26</td><td>1.32</td><td>0.163</td><td>0.281</td><td>1.000</td><td>142</td><td>tags=34%, list=18%, signal=40%</td></tr><tr><td class='lessen'>194</td><td>GRAESSMANN_APOPTOSIS_BY_DOXORUBICIN_UP</td><td></td><td>79</td><td>0.21</td><td>1.32</td><td>0.096</td><td>0.283</td><td>1.000</td><td>175</td><td>tags=32%, list=23%, signal=37%</td></tr><tr><td class='lessen'>195</td><td>KINSEY_TARGETS_OF_EWSR1_FLII_FUSION_DN</td><td></td><td>21</td><td>0.30</td><td>1.32</td><td>0.120</td><td>0.284</td><td>1.000</td><td>146</td><td>tags=38%, list=19%, signal=46%</td></tr><tr><td class='lessen'>196</td><td>MARSON_FOXP3_TARGETS_UP</td><td></td><td>17</td><td>0.34</td><td>1.32</td><td>0.153</td><td>0.284</td><td>1.000</td><td>58</td><td>tags=24%, list=8%, signal=25%</td></tr><tr><td class='lessen'>197</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_AND_PROGENITOR</td><td></td><td>27</td><td>0.28</td><td>1.32</td><td>0.140</td><td>0.286</td><td>1.000</td><td>157</td><td>tags=33%, list=20%, signal=40%</td></tr><tr><td class='lessen'>198</td><td>MEBARKI_HCC_PROGENITOR_WNT_UP</td><td></td><td>15</td><td>0.34</td><td>1.31</td><td>0.158</td><td>0.289</td><td>1.000</td><td>121</td><td>tags=40%, list=16%, signal=47%</td></tr><tr><td class='lessen'>199</td><td>WEST_ADRENOCORTICAL_TUMOR_UP</td><td></td><td>16</td><td>0.34</td><td>1.31</td><td>0.165</td><td>0.291</td><td>1.000</td><td>285</td><td>tags=69%, list=37%, signal=107%</td></tr><tr><td class='lessen'>200</td><td>BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP</td><td></td><td>24</td><td>0.29</td><td>1.31</td><td>0.150</td><td>0.291</td><td>1.000</td><td>226</td><td>tags=50%, list=29%, signal=69%</td></tr><tr><td class='lessen'>201</td><td>REACTOME_NERVOUS_SYSTEM_DEVELOPMENT</td><td></td><td>66</td><td>0.21</td><td>1.31</td><td>0.120</td><td>0.291</td><td>1.000</td><td>49</td><td>tags=15%, list=6%, signal=15%</td></tr><tr><td class='lessen'>202</td><td>GRAESSMANN_APOPTOSIS_BY_SERUM_DEPRIVATION_DN</td><td></td><td>18</td><td>0.32</td><td>1.30</td><td>0.162</td><td>0.301</td><td>1.000</td><td>154</td><td>tags=44%, list=20%, signal=54%</td></tr><tr><td class='lessen'>203</td><td>MARTINEZ_TP53_TARGETS_DN</td><td></td><td>60</td><td>0.22</td><td>1.29</td><td>0.127</td><td>0.304</td><td>1.000</td><td>184</td><td>tags=35%, list=24%, signal=42%</td></tr><tr><td class='lessen'>204</td><td>FERNANDEZ_BOUND_BY_MYC</td><td></td><td>15</td><td>0.32</td><td>1.29</td><td>0.211</td><td>0.307</td><td>1.000</td><td>106</td><td>tags=33%, list=14%, signal=38%</td></tr><tr><td class='lessen'>205</td><td>PHONG_TNF_RESPONSE_VIA_P38_PARTIAL</td><td></td><td>18</td><td>0.31</td><td>1.28</td><td>0.216</td><td>0.315</td><td>1.000</td><td>423</td><td>tags=89%, list=55%, signal=193%</td></tr><tr><td class='lessen'>206</td><td>MITSIADES_RESPONSE_TO_APLIDIN_UP</td><td></td><td>28</td><td>0.27</td><td>1.28</td><td>0.167</td><td>0.321</td><td>1.000</td><td>237</td><td>tags=54%, list=31%, signal=75%</td></tr><tr><td class='lessen'>207</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1</td><td></td><td>28</td><td>0.27</td><td>1.27</td><td>0.141</td><td>0.328</td><td>1.000</td><td>124</td><td>tags=29%, list=16%, signal=33%</td></tr><tr><td class='lessen'>208</td><td>FARMER_BREAST_CANCER_APOCRINE_VS_BASAL</td><td></td><td>36</td><td>0.24</td><td>1.27</td><td>0.159</td><td>0.333</td><td>1.000</td><td>33</td><td>tags=14%, list=4%, signal=14%</td></tr><tr><td class='lessen'>209</td><td>LAIHO_COLORECTAL_CANCER_SERRATED_UP</td><td></td><td>21</td><td>0.30</td><td>1.26</td><td>0.191</td><td>0.334</td><td>1.000</td><td>252</td><td>tags=62%, list=33%, signal=90%</td></tr><tr><td class='lessen'>210</td><td>KUMAR_TARGETS_OF_MLL_AF9_FUSION</td><td></td><td>35</td><td>0.25</td><td>1.26</td><td>0.161</td><td>0.333</td><td>1.000</td><td>160</td><td>tags=37%, list=21%, signal=45%</td></tr><tr><td class='lessen'>211</td><td>BOUDOUKHA_BOUND_BY_IGF2BP2</td><td></td><td>17</td><td>0.33</td><td>1.26</td><td>0.213</td><td>0.332</td><td>1.000</td><td>153</td><td>tags=35%, list=20%, signal=43%</td></tr><tr><td class='lessen'>212</td><td>REACTOME_MEMBRANE_TRAFFICKING</td><td></td><td>34</td><td>0.25</td><td>1.26</td><td>0.187</td><td>0.331</td><td>1.000</td><td>248</td><td>tags=50%, list=32%, signal=71%</td></tr><tr><td class='lessen'>213</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP</td><td></td><td>57</td><td>0.22</td><td>1.26</td><td>0.172</td><td>0.329</td><td>1.000</td><td>76</td><td>tags=23%, list=10%, signal=23%</td></tr><tr><td class='lessen'>214</td><td>REACTOME_TRANSLATION</td><td></td><td>58</td><td>0.22</td><td>1.26</td><td>0.178</td><td>0.336</td><td>1.000</td><td>49</td><td>tags=16%, list=6%, signal=15%</td></tr><tr><td class='lessen'>215</td><td>SHEDDEN_LUNG_CANCER_POOR_SURVIVAL_A6</td><td></td><td>23</td><td>0.28</td><td>1.25</td><td>0.150</td><td>0.337</td><td>1.000</td><td>204</td><td>tags=43%, list=27%, signal=57%</td></tr><tr><td class='lessen'>216</td><td>JIANG_HYPOXIA_NORMAL</td><td></td><td>22</td><td>0.29</td><td>1.25</td><td>0.200</td><td>0.340</td><td>1.000</td><td>158</td><td>tags=36%, list=21%, signal=44%</td></tr><tr><td class='lessen'>217</td><td>DAVICIONI_TARGETS_OF_PAX_FOXO1_FUSIONS_UP</td><td></td><td>20</td><td>0.29</td><td>1.25</td><td>0.209</td><td>0.339</td><td>1.000</td><td>341</td><td>tags=75%, list=44%, signal=131%</td></tr><tr><td class='lessen'>218</td><td>MARTENS_BOUND_BY_PML_RARA_FUSION</td><td></td><td>23</td><td>0.28</td><td>1.25</td><td>0.162</td><td>0.338</td><td>1.000</td><td>160</td><td>tags=35%, list=21%, signal=43%</td></tr><tr><td class='lessen'>219</td><td>PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN</td><td></td><td>24</td><td>0.28</td><td>1.24</td><td>0.153</td><td>0.344</td><td>1.000</td><td>69</td><td>tags=25%, list=9%, signal=27%</td></tr><tr><td class='lessen'>220</td><td>CONCANNON_APOPTOSIS_BY_EPOXOMICIN_DN</td><td></td><td>20</td><td>0.30</td><td>1.24</td><td>0.211</td><td>0.346</td><td>1.000</td><td>291</td><td>tags=70%, list=38%, signal=110%</td></tr><tr><td class='lessen'>221</td><td>FORTSCHEGGER_PHF8_TARGETS_DN</td><td></td><td>61</td><td>0.21</td><td>1.24</td><td>0.155</td><td>0.347</td><td>1.000</td><td>344</td><td>tags=64%, list=45%, signal=107%</td></tr><tr><td class='lessen'>222</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN</td><td></td><td>26</td><td>0.27</td><td>1.24</td><td>0.199</td><td>0.349</td><td>1.000</td><td>85</td><td>tags=27%, list=11%, signal=29%</td></tr><tr><td class='lessen'>223</td><td>GEORGES_TARGETS_OF_MIR192_AND_MIR215</td><td></td><td>37</td><td>0.24</td><td>1.23</td><td>0.180</td><td>0.353</td><td>1.000</td><td>295</td><td>tags=62%, list=38%, signal=96%</td></tr><tr><td class='lessen'>224</td><td>WANG_SMARCE1_TARGETS_UP</td><td></td><td>18</td><td>0.31</td><td>1.23</td><td>0.237</td><td>0.354</td><td>1.000</td><td>231</td><td>tags=56%, list=30%, signal=78%</td></tr><tr><td class='lessen'>225</td><td>JAATINEN_HEMATOPOIETIC_STEM_CELL_UP</td><td></td><td>16</td><td>0.31</td><td>1.23</td><td>0.227</td><td>0.357</td><td>1.000</td><td>33</td><td>tags=25%, list=4%, signal=26%</td></tr><tr><td class='lessen'>226</td><td>KAAB_FAILED_HEART_ATRIUM_DN</td><td></td><td>20</td><td>0.28</td><td>1.22</td><td>0.235</td><td>0.361</td><td>1.000</td><td>264</td><td>tags=55%, list=34%, signal=82%</td></tr><tr><td class='lessen'>227</td><td>REACTOME_METABOLISM_OF_AMINO_ACIDS_AND_DERIVATIVES</td><td></td><td>65</td><td>0.20</td><td>1.22</td><td>0.183</td><td>0.360</td><td>1.000</td><td>59</td><td>tags=17%, list=8%, signal=17%</td></tr><tr><td class='lessen'>228</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_UP</td><td></td><td>18</td><td>0.30</td><td>1.22</td><td>0.248</td><td>0.363</td><td>1.000</td><td>163</td><td>tags=39%, list=21%, signal=48%</td></tr><tr><td class='lessen'>229</td><td>SERVITJA_LIVER_HNF1A_TARGETS_UP</td><td></td><td>15</td><td>0.33</td><td>1.22</td><td>0.216</td><td>0.363</td><td>1.000</td><td>28</td><td>tags=27%, list=4%, signal=27%</td></tr><tr><td class='lessen'>230</td><td>HILLION_HMGA1B_TARGETS</td><td></td><td>23</td><td>0.27</td><td>1.22</td><td>0.236</td><td>0.362</td><td>1.000</td><td>121</td><td>tags=30%, list=16%, signal=35%</td></tr><tr><td class='lessen'>231</td><td>WINTER_HYPOXIA_METAGENE</td><td></td><td>35</td><td>0.24</td><td>1.22</td><td>0.207</td><td>0.362</td><td>1.000</td><td>155</td><td>tags=43%, list=20%, signal=51%</td></tr><tr><td class='lessen'>232</td><td>KIM_WT1_TARGETS_12HR_DN</td><td></td><td>18</td><td>0.30</td><td>1.22</td><td>0.220</td><td>0.361</td><td>1.000</td><td>395</td><td>tags=83%, list=51%, signal=167%</td></tr><tr><td class='lessen'>233</td><td>ENK_UV_RESPONSE_EPIDERMIS_DN</td><td></td><td>42</td><td>0.23</td><td>1.21</td><td>0.194</td><td>0.363</td><td>1.000</td><td>47</td><td>tags=17%, list=6%, signal=17%</td></tr><tr><td class='lessen'>234</td><td>MALONEY_RESPONSE_TO_17AAG_DN</td><td></td><td>17</td><td>0.30</td><td>1.21</td><td>0.232</td><td>0.375</td><td>1.000</td><td>289</td><td>tags=71%, list=38%, signal=111%</td></tr><tr><td class='lessen'>235</td><td>BILD_HRAS_ONCOGENIC_SIGNATURE</td><td></td><td>27</td><td>0.26</td><td>1.20</td><td>0.205</td><td>0.380</td><td>1.000</td><td>321</td><td>tags=67%, list=42%, signal=110%</td></tr><tr><td class='lessen'>236</td><td>ELVIDGE_HIF1A_AND_HIF2A_TARGETS_DN</td><td></td><td>17</td><td>0.30</td><td>1.20</td><td>0.240</td><td>0.382</td><td>1.000</td><td>155</td><td>tags=41%, list=20%, signal=50%</td></tr><tr><td class='lessen'>237</td><td>GARY_CD5_TARGETS_UP</td><td></td><td>34</td><td>0.24</td><td>1.20</td><td>0.253</td><td>0.381</td><td>1.000</td><td>172</td><td>tags=38%, list=22%, signal=47%</td></tr><tr><td class='lessen'>238</td><td>SASAKI_ADULT_T_CELL_LEUKEMIA</td><td></td><td>15</td><td>0.31</td><td>1.20</td><td>0.246</td><td>0.383</td><td>1.000</td><td>383</td><td>tags=80%, list=50%, signal=156%</td></tr><tr><td class='lessen'>239</td><td>AGUIRRE_PANCREATIC_CANCER_COPY_NUMBER_UP</td><td></td><td>17</td><td>0.30</td><td>1.18</td><td>0.248</td><td>0.404</td><td>1.000</td><td>482</td><td>tags=94%, list=63%, signal=247%</td></tr><tr><td class='lessen'>240</td><td>MULLIGHAN_MLL_SIGNATURE_1_UP</td><td></td><td>29</td><td>0.25</td><td>1.18</td><td>0.258</td><td>0.405</td><td>1.000</td><td>91</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>241</td><td>LEE_BMP2_TARGETS_DN</td><td></td><td>32</td><td>0.24</td><td>1.18</td><td>0.241</td><td>0.407</td><td>1.000</td><td>168</td><td>tags=41%, list=22%, signal=50%</td></tr><tr><td class='lessen'>242</td><td>MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP</td><td></td><td>17</td><td>0.30</td><td>1.17</td><td>0.264</td><td>0.408</td><td>1.000</td><td>216</td><td>tags=53%, list=28%, signal=72%</td></tr><tr><td class='lessen'>243</td><td>REACTOME_PLATELET_ACTIVATION_SIGNALING_AND_AGGREGATION</td><td></td><td>18</td><td>0.29</td><td>1.17</td><td>0.245</td><td>0.410</td><td>1.000</td><td>166</td><td>tags=50%, list=22%, signal=62%</td></tr><tr><td class='lessen'>244</td><td>ENK_UV_RESPONSE_KERATINOCYTE_UP</td><td></td><td>77</td><td>0.18</td><td>1.16</td><td>0.247</td><td>0.429</td><td>1.000</td><td>80</td><td>tags=17%, list=10%, signal=17%</td></tr><tr><td class='lessen'>245</td><td>HELLER_HDAC_TARGETS_DN</td><td></td><td>19</td><td>0.28</td><td>1.16</td><td>0.287</td><td>0.428</td><td>1.000</td><td>163</td><td>tags=37%, list=21%, signal=46%</td></tr><tr><td class='lessen'>246</td><td>MARSON_BOUND_BY_FOXP3_UNSTIMULATED</td><td></td><td>77</td><td>0.19</td><td>1.15</td><td>0.256</td><td>0.436</td><td>1.000</td><td>196</td><td>tags=38%, list=25%, signal=45%</td></tr><tr><td class='lessen'>247</td><td>GRYDER_PAX3FOXO1_TOP_ENHANCERS</td><td></td><td>28</td><td>0.25</td><td>1.15</td><td>0.290</td><td>0.437</td><td>1.000</td><td>238</td><td>tags=50%, list=31%, signal=70%</td></tr><tr><td class='lessen'>248</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>19</td><td>0.29</td><td>1.15</td><td>0.300</td><td>0.438</td><td>1.000</td><td>217</td><td>tags=53%, list=28%, signal=72%</td></tr><tr><td class='lessen'>249</td><td>COLDREN_GEFITINIB_RESISTANCE_DN</td><td></td><td>20</td><td>0.27</td><td>1.15</td><td>0.307</td><td>0.440</td><td>1.000</td><td>149</td><td>tags=45%, list=19%, signal=54%</td></tr><tr><td class='lessen'>250</td><td>GROSS_HYPOXIA_VIA_ELK3_DN</td><td></td><td>16</td><td>0.30</td><td>1.15</td><td>0.274</td><td>0.439</td><td>1.000</td><td>204</td><td>tags=63%, list=27%, signal=83%</td></tr><tr><td class='lessen'>251</td><td>FOSTER_TOLERANT_MACROPHAGE_DN</td><td></td><td>23</td><td>0.26</td><td>1.14</td><td>0.303</td><td>0.441</td><td>1.000</td><td>295</td><td>tags=61%, list=38%, signal=96%</td></tr><tr><td class='lessen'>252</td><td>BASSO_B_LYMPHOCYTE_NETWORK</td><td></td><td>17</td><td>0.29</td><td>1.14</td><td>0.296</td><td>0.441</td><td>1.000</td><td>328</td><td>tags=71%, list=43%, signal=120%</td></tr><tr><td class='lessen'>253</td><td>BROWNE_HCMV_INFECTION_14HR_DN</td><td></td><td>22</td><td>0.26</td><td>1.14</td><td>0.304</td><td>0.443</td><td>1.000</td><td>209</td><td>tags=50%, list=27%, signal=67%</td></tr><tr><td class='lessen'>254</td><td>DANG_REGULATED_BY_MYC_DN</td><td></td><td>32</td><td>0.24</td><td>1.14</td><td>0.298</td><td>0.441</td><td>1.000</td><td>132</td><td>tags=34%, list=17%, signal=40%</td></tr><tr><td class='lessen'>255</td><td>BAELDE_DIABETIC_NEPHROPATHY_DN</td><td></td><td>40</td><td>0.21</td><td>1.13</td><td>0.290</td><td>0.446</td><td>1.000</td><td>326</td><td>tags=63%, list=42%, signal=103%</td></tr><tr><td class='lessen'>256</td><td>PHONG_TNF_RESPONSE_NOT_VIA_P38</td><td></td><td>25</td><td>0.25</td><td>1.13</td><td>0.318</td><td>0.451</td><td>1.000</td><td>321</td><td>tags=64%, list=42%, signal=106%</td></tr><tr><td class='lessen'>257</td><td>CHEN_METABOLIC_SYNDROM_NETWORK</td><td></td><td>102</td><td>0.17</td><td>1.13</td><td>0.265</td><td>0.454</td><td>1.000</td><td>151</td><td>tags=27%, list=20%, signal=30%</td></tr><tr><td class='lessen'>258</td><td>SPIELMAN_LYMPHOBLAST_EUROPEAN_VS_ASIAN_UP</td><td></td><td>65</td><td>0.18</td><td>1.12</td><td>0.294</td><td>0.463</td><td>1.000</td><td>306</td><td>tags=57%, list=40%, signal=87%</td></tr><tr><td class='lessen'>259</td><td>RODRIGUES_NTN1_TARGETS_DN</td><td></td><td>24</td><td>0.24</td><td>1.12</td><td>0.315</td><td>0.462</td><td>1.000</td><td>68</td><td>tags=21%, list=9%, signal=22%</td></tr><tr><td class='lessen'>260</td><td>PUJANA_CHEK2_PCC_NETWORK</td><td></td><td>53</td><td>0.20</td><td>1.12</td><td>0.314</td><td>0.463</td><td>1.000</td><td>292</td><td>tags=55%, list=38%, signal=82%</td></tr><tr><td class='lessen'>261</td><td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td><td></td><td>16</td><td>0.28</td><td>1.12</td><td>0.308</td><td>0.463</td><td>1.000</td><td>321</td><td>tags=69%, list=42%, signal=116%</td></tr><tr><td class='lessen'>262</td><td>WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP</td><td></td><td>19</td><td>0.27</td><td>1.12</td><td>0.313</td><td>0.462</td><td>1.000</td><td>189</td><td>tags=47%, list=25%, signal=61%</td></tr><tr><td class='lessen'>263</td><td>REACTOME_TRANSCRIPTIONAL_REGULATION_BY_TP53</td><td></td><td>20</td><td>0.27</td><td>1.12</td><td>0.338</td><td>0.461</td><td>1.000</td><td>133</td><td>tags=35%, list=17%, signal=41%</td></tr><tr><td class='lessen'>264</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_UP</td><td></td><td>21</td><td>0.26</td><td>1.12</td><td>0.331</td><td>0.460</td><td>1.000</td><td>55</td><td>tags=24%, list=7%, signal=25%</td></tr><tr><td class='lessen'>265</td><td>WONG_EMBRYONIC_STEM_CELL_CORE</td><td></td><td>27</td><td>0.24</td><td>1.12</td><td>0.304</td><td>0.458</td><td>1.000</td><td>226</td><td>tags=48%, list=29%, signal=66%</td></tr><tr><td class='lessen'>266</td><td>XU_GH1_AUTOCRINE_TARGETS_DN</td><td></td><td>15</td><td>0.29</td><td>1.11</td><td>0.312</td><td>0.470</td><td>1.000</td><td>58</td><td>tags=27%, list=8%, signal=28%</td></tr><tr><td class='lessen'>267</td><td>WP_VITAMIN_D_RECEPTOR_PATHWAY</td><td></td><td>18</td><td>0.27</td><td>1.11</td><td>0.358</td><td>0.469</td><td>1.000</td><td>47</td><td>tags=17%, list=6%, signal=17%</td></tr><tr><td class='lessen'>268</td><td>FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP</td><td></td><td>44</td><td>0.20</td><td>1.11</td><td>0.340</td><td>0.468</td><td>1.000</td><td>239</td><td>tags=45%, list=31%, signal=62%</td></tr><tr><td class='lessen'>269</td><td>MUELLER_PLURINET</td><td></td><td>19</td><td>0.27</td><td>1.10</td><td>0.312</td><td>0.476</td><td>1.000</td><td>340</td><td>tags=68%, list=44%, signal=120%</td></tr><tr><td class='lessen'>270</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP</td><td></td><td>16</td><td>0.28</td><td>1.10</td><td>0.330</td><td>0.482</td><td>1.000</td><td>231</td><td>tags=50%, list=30%, signal=70%</td></tr><tr><td class='lessen'>271</td><td>ZHANG_BREAST_CANCER_PROGENITORS_UP</td><td></td><td>20</td><td>0.26</td><td>1.09</td><td>0.344</td><td>0.485</td><td>1.000</td><td>193</td><td>tags=45%, list=25%, signal=59%</td></tr><tr><td class='lessen'>272</td><td>DAIRKEE_CANCER_PRONE_RESPONSE_BPA_E2</td><td></td><td>15</td><td>0.28</td><td>1.09</td><td>0.346</td><td>0.494</td><td>1.000</td><td>555</td><td>tags=100%, list=72%, signal=352%</td></tr><tr><td class='lessen'>273</td><td>UDAYAKUMAR_MED1_TARGETS_UP</td><td></td><td>15</td><td>0.28</td><td>1.09</td><td>0.356</td><td>0.493</td><td>1.000</td><td>333</td><td>tags=73%, list=43%, signal=127%</td></tr><tr><td class='lessen'>274</td><td>HUPER_BREAST_BASAL_VS_LUMINAL_DN</td><td></td><td>15</td><td>0.29</td><td>1.08</td><td>0.347</td><td>0.498</td><td>1.000</td><td>148</td><td>tags=53%, list=19%, signal=65%</td></tr><tr><td class='lessen'>275</td><td>CAIRO_HEPATOBLASTOMA_CLASSES_UP</td><td></td><td>46</td><td>0.19</td><td>1.08</td><td>0.360</td><td>0.498</td><td>1.000</td><td>628</td><td>tags=100%, list=82%, signal=513%</td></tr><tr><td class='lessen'>276</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_DN</td><td></td><td>43</td><td>0.20</td><td>1.07</td><td>0.369</td><td>0.506</td><td>1.000</td><td>29</td><td>tags=12%, list=4%, signal=11%</td></tr><tr><td class='lessen'>277</td><td>ENK_UV_RESPONSE_EPIDERMIS_UP</td><td></td><td>32</td><td>0.21</td><td>1.07</td><td>0.378</td><td>0.515</td><td>1.000</td><td>338</td><td>tags=66%, list=44%, signal=112%</td></tr><tr><td class='lessen'>278</td><td>YAMAZAKI_TCEB3_TARGETS_UP</td><td></td><td>16</td><td>0.27</td><td>1.05</td><td>0.404</td><td>0.536</td><td>1.000</td><td>29</td><td>tags=19%, list=4%, signal=19%</td></tr><tr><td class='lessen'>279</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP</td><td></td><td>44</td><td>0.19</td><td>1.05</td><td>0.401</td><td>0.541</td><td>1.000</td><td>230</td><td>tags=45%, list=30%, signal=61%</td></tr><tr><td class='lessen'>280</td><td>REACTOME_VESICLE_MEDIATED_TRANSPORT</td><td></td><td>37</td><td>0.20</td><td>1.05</td><td>0.385</td><td>0.541</td><td>1.000</td><td>110</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>281</td><td>BENPORATH_NANOG_TARGETS</td><td></td><td>52</td><td>0.19</td><td>1.05</td><td>0.434</td><td>0.544</td><td>1.000</td><td>269</td><td>tags=50%, list=35%, signal=72%</td></tr><tr><td class='lessen'>282</td><td>ENK_UV_RESPONSE_KERATINOCYTE_DN</td><td></td><td>33</td><td>0.22</td><td>1.04</td><td>0.378</td><td>0.544</td><td>1.000</td><td>334</td><td>tags=70%, list=43%, signal=118%</td></tr><tr><td class='lessen'>283</td><td>RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_DN</td><td></td><td>47</td><td>0.19</td><td>1.04</td><td>0.399</td><td>0.550</td><td>1.000</td><td>67</td><td>tags=17%, list=9%, signal=18%</td></tr><tr><td class='lessen'>284</td><td>TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>23</td><td>0.24</td><td>1.04</td><td>0.428</td><td>0.553</td><td>1.000</td><td>37</td><td>tags=13%, list=5%, signal=13%</td></tr><tr><td class='lessen'>285</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_17</td><td></td><td>25</td><td>0.22</td><td>1.03</td><td>0.383</td><td>0.556</td><td>1.000</td><td>109</td><td>tags=24%, list=14%, signal=27%</td></tr><tr><td class='lessen'>286</td><td>DIAZ_CHRONIC_MEYLOGENOUS_LEUKEMIA_UP</td><td></td><td>126</td><td>0.15</td><td>1.03</td><td>0.415</td><td>0.559</td><td>1.000</td><td>329</td><td>tags=54%, list=43%, signal=79%</td></tr><tr><td class='lessen'>287</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td></td><td>24</td><td>0.23</td><td>1.03</td><td>0.457</td><td>0.568</td><td>1.000</td><td>95</td><td>tags=21%, list=12%, signal=23%</td></tr><tr><td class='lessen'>288</td><td>DELACROIX_RAR_BOUND_ES</td><td></td><td>32</td><td>0.20</td><td>1.03</td><td>0.449</td><td>0.566</td><td>1.000</td><td>282</td><td>tags=56%, list=37%, signal=85%</td></tr><tr><td class='lessen'>289</td><td>GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td><td></td><td>38</td><td>0.20</td><td>1.02</td><td>0.432</td><td>0.566</td><td>1.000</td><td>120</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>290</td><td>WP_NRF2_PATHWAY</td><td></td><td>25</td><td>0.23</td><td>1.02</td><td>0.422</td><td>0.573</td><td>1.000</td><td>126</td><td>tags=32%, list=16%, signal=37%</td></tr><tr><td class='lessen'>291</td><td>BLALOCK_ALZHEIMERS_DISEASE_UP</td><td></td><td>99</td><td>0.16</td><td>1.02</td><td>0.425</td><td>0.575</td><td>1.000</td><td>60</td><td>tags=13%, list=8%, signal=12%</td></tr><tr><td class='lessen'>292</td><td>REACTOME_CELL_CYCLE</td><td></td><td>34</td><td>0.20</td><td>1.01</td><td>0.446</td><td>0.580</td><td>1.000</td><td>135</td><td>tags=29%, list=18%, signal=34%</td></tr><tr><td class='lessen'>293</td><td>UEDA_PERIFERAL_CLOCK</td><td></td><td>21</td><td>0.23</td><td>1.01</td><td>0.435</td><td>0.588</td><td>1.000</td><td>305</td><td>tags=67%, list=40%, signal=107%</td></tr><tr><td class='lessen'>294</td><td>WAMUNYOKOLI_OVARIAN_CANCER_LMP_UP</td><td></td><td>43</td><td>0.19</td><td>1.00</td><td>0.487</td><td>0.589</td><td>1.000</td><td>110</td><td>tags=21%, list=14%, signal=23%</td></tr><tr><td class='lessen'>295</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_6HR_DN</td><td></td><td>45</td><td>0.18</td><td>1.00</td><td>0.484</td><td>0.592</td><td>1.000</td><td>304</td><td>tags=60%, list=40%, signal=93%</td></tr><tr><td class='lessen'>296</td><td>JISON_SICKLE_CELL_DISEASE_UP</td><td></td><td>23</td><td>0.23</td><td>1.00</td><td>0.471</td><td>0.595</td><td>1.000</td><td>71</td><td>tags=22%, list=9%, signal=23%</td></tr><tr><td class='lessen'>297</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_ERYTHROID_DN</td><td></td><td>21</td><td>0.23</td><td>1.00</td><td>0.446</td><td>0.594</td><td>1.000</td><td>198</td><td>tags=48%, list=26%, signal=62%</td></tr><tr><td class='lessen'>298</td><td>TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP</td><td></td><td>17</td><td>0.25</td><td>0.99</td><td>0.438</td><td>0.598</td><td>1.000</td><td>28</td><td>tags=18%, list=4%, signal=18%</td></tr><tr><td class='lessen'>299</td><td>SCHLOSSER_SERUM_RESPONSE_DN</td><td></td><td>74</td><td>0.16</td><td>0.99</td><td>0.508</td><td>0.597</td><td>1.000</td><td>256</td><td>tags=49%, list=33%, signal=66%</td></tr><tr><td class='lessen'>300</td><td>YOSHIMURA_MAPK8_TARGETS_DN</td><td></td><td>32</td><td>0.20</td><td>0.98</td><td>0.486</td><td>0.613</td><td>1.000</td><td>192</td><td>tags=38%, list=25%, signal=48%</td></tr><tr><td class='lessen'>301</td><td>LIM_MAMMARY_STEM_CELL_DN</td><td></td><td>42</td><td>0.18</td><td>0.98</td><td>0.492</td><td>0.615</td><td>1.000</td><td>148</td><td>tags=31%, list=19%, signal=36%</td></tr><tr><td class='lessen'>302</td><td>PILON_KLF1_TARGETS_UP</td><td></td><td>25</td><td>0.21</td><td>0.98</td><td>0.472</td><td>0.614</td><td>1.000</td><td>226</td><td>tags=44%, list=29%, signal=60%</td></tr><tr><td class='lessen'>303</td><td>JOHNSTONE_PARVB_TARGETS_3_DN</td><td></td><td>33</td><td>0.20</td><td>0.98</td><td>0.484</td><td>0.616</td><td>1.000</td><td>228</td><td>tags=45%, list=30%, signal=62%</td></tr><tr><td class='lessen'>304</td><td>HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN</td><td></td><td>23</td><td>0.23</td><td>0.98</td><td>0.495</td><td>0.615</td><td>1.000</td><td>168</td><td>tags=35%, list=22%, signal=43%</td></tr><tr><td class='lessen'>305</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_DN</td><td></td><td>15</td><td>0.26</td><td>0.98</td><td>0.506</td><td>0.615</td><td>1.000</td><td>151</td><td>tags=40%, list=20%, signal=49%</td></tr><tr><td class='lessen'>306</td><td>KOYAMA_SEMA3B_TARGETS_DN</td><td></td><td>23</td><td>0.23</td><td>0.97</td><td>0.493</td><td>0.624</td><td>1.000</td><td>236</td><td>tags=48%, list=31%, signal=67%</td></tr><tr><td class='lessen'>307</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN</td><td></td><td>60</td><td>0.16</td><td>0.97</td><td>0.536</td><td>0.627</td><td>1.000</td><td>253</td><td>tags=43%, list=33%, signal=60%</td></tr><tr><td class='lessen'>308</td><td>CUI_TCF21_TARGETS_2_DN</td><td></td><td>41</td><td>0.18</td><td>0.96</td><td>0.542</td><td>0.641</td><td>1.000</td><td>324</td><td>tags=68%, list=42%, signal=112%</td></tr><tr><td class='lessen'>309</td><td>WANG_TUMOR_INVASIVENESS_DN</td><td></td><td>24</td><td>0.21</td><td>0.95</td><td>0.556</td><td>0.647</td><td>1.000</td><td>220</td><td>tags=46%, list=29%, signal=62%</td></tr><tr><td class='lessen'>310</td><td>ALONSO_METASTASIS_UP</td><td></td><td>24</td><td>0.22</td><td>0.95</td><td>0.516</td><td>0.649</td><td>1.000</td><td>197</td><td>tags=46%, list=26%, signal=60%</td></tr><tr><td class='lessen'>311</td><td>REACTOME_ACTIVATION_OF_THE_MRNA_UPON_BINDING_OF_THE_CAP_BINDING_COMPLEX_AND_EIFS_AND_SUBSEQUENT_BINDING_TO_43S</td><td></td><td>22</td><td>0.22</td><td>0.94</td><td>0.508</td><td>0.656</td><td>1.000</td><td>219</td><td>tags=41%, list=28%, signal=56%</td></tr><tr><td class='lessen'>312</td><td>WAKABAYASHI_ADIPOGENESIS_PPARG_BOUND_8D</td><td></td><td>43</td><td>0.17</td><td>0.94</td><td>0.545</td><td>0.658</td><td>1.000</td><td>68</td><td>tags=16%, list=9%, signal=17%</td></tr><tr><td class='lessen'>313</td><td>GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN</td><td></td><td>48</td><td>0.17</td><td>0.94</td><td>0.568</td><td>0.659</td><td>1.000</td><td>217</td><td>tags=40%, list=28%, signal=52%</td></tr><tr><td class='lessen'>314</td><td>RUTELLA_RESPONSE_TO_HGF_UP</td><td></td><td>38</td><td>0.18</td><td>0.93</td><td>0.572</td><td>0.672</td><td>1.000</td><td>28</td><td>tags=11%, list=4%, signal=10%</td></tr><tr><td class='lessen'>315</td><td>REACTOME_DISEASES_OF_SIGNAL_TRANSDUCTION_BY_GROWTH_FACTOR_RECEPTORS_AND_SECOND_MESSENGERS</td><td></td><td>33</td><td>0.19</td><td>0.93</td><td>0.559</td><td>0.673</td><td>1.000</td><td>43</td><td>tags=12%, list=6%, signal=12%</td></tr><tr><td class='lessen'>316</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_UP</td><td></td><td>25</td><td>0.20</td><td>0.92</td><td>0.577</td><td>0.684</td><td>1.000</td><td>142</td><td>tags=32%, list=18%, signal=38%</td></tr><tr><td class='lessen'>317</td><td>PECE_MAMMARY_STEM_CELL_DN</td><td></td><td>15</td><td>0.24</td><td>0.92</td><td>0.540</td><td>0.684</td><td>1.000</td><td>101</td><td>tags=27%, list=13%, signal=30%</td></tr><tr><td class='lessen'>318</td><td>MIKKELSEN_ES_ICP_WITH_H3K4ME3</td><td></td><td>33</td><td>0.19</td><td>0.92</td><td>0.569</td><td>0.682</td><td>1.000</td><td>65</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>319</td><td>WANG_RESPONSE_TO_GSK3_INHIBITOR_SB216763_DN</td><td></td><td>26</td><td>0.20</td><td>0.92</td><td>0.583</td><td>0.682</td><td>1.000</td><td>167</td><td>tags=31%, list=22%, signal=38%</td></tr><tr><td class='lessen'>320</td><td>SHEPARD_CRUSH_AND_BURN_MUTANT_UP</td><td></td><td>16</td><td>0.24</td><td>0.92</td><td>0.512</td><td>0.680</td><td>1.000</td><td>169</td><td>tags=38%, list=22%, signal=47%</td></tr><tr><td class='lessen'>321</td><td>REACTOME_INFECTIOUS_DISEASE</td><td></td><td>93</td><td>0.14</td><td>0.92</td><td>0.645</td><td>0.682</td><td>1.000</td><td>49</td><td>tags=12%, list=6%, signal=11%</td></tr><tr><td class='lessen'>322</td><td>JECHLINGER_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_DN</td><td></td><td>15</td><td>0.24</td><td>0.91</td><td>0.586</td><td>0.684</td><td>1.000</td><td>324</td><td>tags=67%, list=42%, signal=113%</td></tr><tr><td class='lessen'>323</td><td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN</td><td></td><td>61</td><td>0.15</td><td>0.91</td><td>0.581</td><td>0.687</td><td>1.000</td><td>329</td><td>tags=56%, list=43%, signal=90%</td></tr><tr><td class='lessen'>324</td><td>MULLIGHAN_MLL_SIGNATURE_2_DN</td><td></td><td>16</td><td>0.23</td><td>0.91</td><td>0.569</td><td>0.688</td><td>1.000</td><td>225</td><td>tags=50%, list=29%, signal=69%</td></tr><tr><td class='lessen'>325</td><td>BROWNE_HCMV_INFECTION_24HR_DN</td><td></td><td>15</td><td>0.24</td><td>0.91</td><td>0.566</td><td>0.691</td><td>1.000</td><td>108</td><td>tags=27%, list=14%, signal=30%</td></tr><tr><td class='lessen'>326</td><td>CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP</td><td></td><td>19</td><td>0.21</td><td>0.90</td><td>0.587</td><td>0.705</td><td>1.000</td><td>256</td><td>tags=53%, list=33%, signal=77%</td></tr><tr><td class='lessen'>327</td><td>WEI_MYCN_TARGETS_WITH_E_BOX</td><td></td><td>41</td><td>0.16</td><td>0.89</td><td>0.614</td><td>0.710</td><td>1.000</td><td>144</td><td>tags=27%, list=19%, signal=31%</td></tr><tr><td class='lessen'>328</td><td>NUYTTEN_NIPP1_TARGETS_DN</td><td></td><td>68</td><td>0.15</td><td>0.89</td><td>0.683</td><td>0.714</td><td>1.000</td><td>331</td><td>tags=63%, list=43%, signal=101%</td></tr><tr><td class='lessen'>329</td><td>CHNG_MULTIPLE_MYELOMA_HYPERPLOID_UP</td><td></td><td>17</td><td>0.23</td><td>0.88</td><td>0.598</td><td>0.722</td><td>1.000</td><td>44</td><td>tags=18%, list=6%, signal=18%</td></tr><tr><td class='lessen'>330</td><td>RIZKI_TUMOR_INVASIVENESS_3D_DN</td><td></td><td>22</td><td>0.20</td><td>0.88</td><td>0.628</td><td>0.728</td><td>1.000</td><td>619</td><td>tags=100%, list=80%, signal=498%</td></tr><tr><td class='lessen'>331</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_5</td><td></td><td>35</td><td>0.17</td><td>0.87</td><td>0.624</td><td>0.740</td><td>1.000</td><td>319</td><td>tags=66%, list=41%, signal=107%</td></tr><tr><td class='lessen'>332</td><td>HOLLMANN_APOPTOSIS_VIA_CD40_DN</td><td></td><td>32</td><td>0.18</td><td>0.86</td><td>0.677</td><td>0.743</td><td>1.000</td><td>124</td><td>tags=22%, list=16%, signal=25%</td></tr><tr><td class='lessen'>333</td><td>MOHANKUMAR_HOXA1_TARGETS_UP</td><td></td><td>30</td><td>0.18</td><td>0.86</td><td>0.688</td><td>0.745</td><td>1.000</td><td>200</td><td>tags=37%, list=26%, signal=48%</td></tr><tr><td class='lessen'>334</td><td>HAMAI_APOPTOSIS_VIA_TRAIL_UP</td><td></td><td>24</td><td>0.19</td><td>0.85</td><td>0.667</td><td>0.757</td><td>1.000</td><td>191</td><td>tags=46%, list=25%, signal=59%</td></tr><tr><td class='lessen'>335</td><td>REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION</td><td></td><td>66</td><td>0.14</td><td>0.85</td><td>0.737</td><td>0.758</td><td>1.000</td><td>11</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>336</td><td>PATIL_LIVER_CANCER</td><td></td><td>38</td><td>0.16</td><td>0.85</td><td>0.674</td><td>0.760</td><td>1.000</td><td>57</td><td>tags=16%, list=7%, signal=16%</td></tr><tr><td class='lessen'>337</td><td>BONOME_OVARIAN_CANCER_SURVIVAL_OPTIMAL_DEBULKING</td><td></td><td>17</td><td>0.21</td><td>0.84</td><td>0.683</td><td>0.766</td><td>1.000</td><td>59</td><td>tags=18%, list=8%, signal=19%</td></tr><tr><td class='lessen'>338</td><td>WELCSH_BRCA1_TARGETS_UP</td><td></td><td>31</td><td>0.17</td><td>0.84</td><td>0.661</td><td>0.766</td><td>1.000</td><td>237</td><td>tags=48%, list=31%, signal=67%</td></tr><tr><td class='lessen'>339</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM1</td><td></td><td>31</td><td>0.17</td><td>0.84</td><td>0.697</td><td>0.765</td><td>1.000</td><td>295</td><td>tags=61%, list=38%, signal=95%</td></tr><tr><td class='lessen'>340</td><td>MILI_PSEUDOPODIA_HAPTOTAXIS_DN</td><td></td><td>48</td><td>0.15</td><td>0.84</td><td>0.745</td><td>0.764</td><td>1.000</td><td>605</td><td>tags=96%, list=79%, signal=421%</td></tr><tr><td class='lessen'>341</td><td>MOOTHA_PGC</td><td></td><td>63</td><td>0.14</td><td>0.83</td><td>0.774</td><td>0.774</td><td>1.000</td><td>151</td><td>tags=25%, list=20%, signal=29%</td></tr><tr><td class='lessen'>342</td><td>KIM_ALL_DISORDERS_DURATION_CORR_DN</td><td></td><td>18</td><td>0.20</td><td>0.83</td><td>0.670</td><td>0.775</td><td>1.000</td><td>147</td><td>tags=28%, list=19%, signal=34%</td></tr><tr><td class='lessen'>343</td><td>WANG_LMO4_TARGETS_DN</td><td></td><td>16</td><td>0.22</td><td>0.82</td><td>0.672</td><td>0.792</td><td>1.000</td><td>227</td><td>tags=50%, list=30%, signal=69%</td></tr><tr><td class='lessen'>344</td><td>BENPORATH_MYC_TARGETS_WITH_EBOX</td><td></td><td>26</td><td>0.18</td><td>0.81</td><td>0.706</td><td>0.797</td><td>1.000</td><td>97</td><td>tags=19%, list=13%, signal=21%</td></tr><tr><td class='lessen'>345</td><td>KAAB_HEART_ATRIUM_VS_VENTRICLE_UP</td><td></td><td>19</td><td>0.19</td><td>0.81</td><td>0.693</td><td>0.799</td><td>1.000</td><td>226</td><td>tags=47%, list=29%, signal=65%</td></tr><tr><td class='lessen'>346</td><td>RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP</td><td></td><td>41</td><td>0.15</td><td>0.79</td><td>0.770</td><td>0.823</td><td>1.000</td><td>16</td><td>tags=7%, list=2%, signal=7%</td></tr><tr><td class='lessen'>347</td><td>NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_DN</td><td></td><td>49</td><td>0.14</td><td>0.77</td><td>0.791</td><td>0.846</td><td>1.000</td><td>314</td><td>tags=57%, list=41%, signal=90%</td></tr><tr><td class='lessen'>348</td><td>WP_IL18_SIGNALING_PATHWAY</td><td></td><td>21</td><td>0.18</td><td>0.77</td><td>0.720</td><td>0.847</td><td>1.000</td><td>56</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>349</td><td>KOKKINAKIS_METHIONINE_DEPRIVATION_48HR_UP</td><td></td><td>15</td><td>0.20</td><td>0.77</td><td>0.740</td><td>0.846</td><td>1.000</td><td>485</td><td>tags=87%, list=63%, signal=230%</td></tr><tr><td class='lessen'>350</td><td>SWEET_KRAS_ONCOGENIC_SIGNATURE</td><td></td><td>23</td><td>0.17</td><td>0.77</td><td>0.717</td><td>0.843</td><td>1.000</td><td>47</td><td>tags=13%, list=6%, signal=13%</td></tr><tr><td class='lessen'>351</td><td>BENPORATH_PRC2_TARGETS</td><td></td><td>16</td><td>0.19</td><td>0.76</td><td>0.755</td><td>0.847</td><td>1.000</td><td>139</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>352</td><td>BENPORATH_ES_WITH_H3K27ME3</td><td></td><td>31</td><td>0.15</td><td>0.76</td><td>0.822</td><td>0.854</td><td>1.000</td><td>8</td><td>tags=6%, list=1%, signal=6%</td></tr><tr><td class='lessen'>353</td><td>PAL_PRMT5_TARGETS_UP</td><td></td><td>19</td><td>0.18</td><td>0.75</td><td>0.774</td><td>0.853</td><td>1.000</td><td>131</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>354</td><td>MCCABE_BOUND_BY_HOXC6</td><td></td><td>15</td><td>0.19</td><td>0.74</td><td>0.785</td><td>0.867</td><td>1.000</td><td>622</td><td>tags=100%, list=81%, signal=513%</td></tr><tr><td class='lessen'>355</td><td>BENPORATH_EED_TARGETS</td><td></td><td>33</td><td>0.15</td><td>0.74</td><td>0.839</td><td>0.867</td><td>1.000</td><td>249</td><td>tags=42%, list=32%, signal=60%</td></tr><tr><td class='lessen'>356</td><td>KEGG_CELL_ADHESION_MOLECULES_CAMS</td><td></td><td>19</td><td>0.18</td><td>0.74</td><td>0.784</td><td>0.866</td><td>1.000</td><td>112</td><td>tags=26%, list=15%, signal=30%</td></tr><tr><td class='lessen'>357</td><td>REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION</td><td></td><td>55</td><td>0.13</td><td>0.73</td><td>0.865</td><td>0.870</td><td>1.000</td><td>133</td><td>tags=22%, list=17%, signal=24%</td></tr><tr><td class='lessen'>358</td><td>WP_EBOLA_VIRUS_PATHWAY_ON_HOST</td><td></td><td>19</td><td>0.18</td><td>0.73</td><td>0.775</td><td>0.871</td><td>1.000</td><td>23</td><td>tags=11%, list=3%, signal=11%</td></tr><tr><td class='lessen'>359</td><td>HORIUCHI_WTAP_TARGETS_DN</td><td></td><td>24</td><td>0.16</td><td>0.72</td><td>0.835</td><td>0.885</td><td>1.000</td><td>345</td><td>tags=67%, list=45%, signal=117%</td></tr><tr><td class='lessen'>360</td><td>MARTENS_TRETINOIN_RESPONSE_DN</td><td></td><td>74</td><td>0.11</td><td>0.71</td><td>0.909</td><td>0.885</td><td>1.000</td><td>161</td><td>tags=27%, list=21%, signal=31%</td></tr><tr><td class='lessen'>361</td><td>BLUM_RESPONSE_TO_SALIRASIB_UP</td><td></td><td>15</td><td>0.18</td><td>0.71</td><td>0.788</td><td>0.887</td><td>1.000</td><td>188</td><td>tags=40%, list=24%, signal=52%</td></tr><tr><td class='lessen'>362</td><td>MIKKELSEN_NPC_ICP_WITH_H3K4ME3</td><td></td><td>19</td><td>0.17</td><td>0.71</td><td>0.817</td><td>0.889</td><td>1.000</td><td>58</td><td>tags=16%, list=8%, signal=17%</td></tr><tr><td class='lessen'>363</td><td>STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN</td><td></td><td>77</td><td>0.11</td><td>0.70</td><td>0.877</td><td>0.891</td><td>1.000</td><td>17</td><td>tags=4%, list=2%, signal=4%</td></tr><tr><td class='lessen'>364</td><td>HAN_SATB1_TARGETS_UP</td><td></td><td>28</td><td>0.15</td><td>0.70</td><td>0.842</td><td>0.890</td><td>1.000</td><td>329</td><td>tags=57%, list=43%, signal=96%</td></tr><tr><td class='lessen'>365</td><td>PUJANA_ATM_PCC_NETWORK</td><td></td><td>72</td><td>0.11</td><td>0.69</td><td>0.908</td><td>0.899</td><td>1.000</td><td>260</td><td>tags=46%, list=34%, signal=63%</td></tr><tr><td class='lessen'>366</td><td>KIM_BIPOLAR_DISORDER_OLIGODENDROCYTE_DENSITY_CORR_UP</td><td></td><td>90</td><td>0.11</td><td>0.68</td><td>0.941</td><td>0.908</td><td>1.000</td><td>667</td><td>tags=98%, list=87%, signal=651%</td></tr><tr><td class='lessen'>367</td><td>TAKAO_RESPONSE_TO_UVB_RADIATION_UP</td><td></td><td>22</td><td>0.15</td><td>0.68</td><td>0.848</td><td>0.905</td><td>1.000</td><td>120</td><td>tags=23%, list=16%, signal=26%</td></tr><tr><td class='lessen'>368</td><td>FORTSCHEGGER_PHF8_TARGETS_UP</td><td></td><td>17</td><td>0.17</td><td>0.67</td><td>0.849</td><td>0.907</td><td>1.000</td><td>88</td><td>tags=18%, list=11%, signal=19%</td></tr><tr><td class='lessen'>369</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>38</td><td>0.12</td><td>0.66</td><td>0.898</td><td>0.923</td><td>1.000</td><td>44</td><td>tags=11%, list=6%, signal=11%</td></tr><tr><td class='lessen'>370</td><td>BRUINS_UVC_RESPONSE_LATE</td><td></td><td>60</td><td>0.11</td><td>0.65</td><td>0.923</td><td>0.921</td><td>1.000</td><td>11</td><td>tags=5%, list=1%, signal=5%</td></tr><tr><td class='lessen'>371</td><td>KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_DN</td><td></td><td>65</td><td>0.10</td><td>0.65</td><td>0.893</td><td>0.926</td><td>1.000</td><td>228</td><td>tags=37%, list=30%, signal=48%</td></tr><tr><td class='lessen'>372</td><td>BILANGES_RAPAMYCIN_SENSITIVE_VIA_TSC1_AND_TSC2</td><td></td><td>20</td><td>0.15</td><td>0.63</td><td>0.906</td><td>0.937</td><td>1.000</td><td>226</td><td>tags=40%, list=29%, signal=55%</td></tr><tr><td class='lessen'>373</td><td>JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP</td><td></td><td>26</td><td>0.13</td><td>0.63</td><td>0.916</td><td>0.938</td><td>1.000</td><td>669</td><td>tags=100%, list=87%, signal=743%</td></tr><tr><td class='lessen'>374</td><td>RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN</td><td></td><td>33</td><td>0.12</td><td>0.62</td><td>0.910</td><td>0.940</td><td>1.000</td><td>16</td><td>tags=6%, list=2%, signal=6%</td></tr><tr><td class='lessen'>375</td><td>KYNG_DNA_DAMAGE_DN</td><td></td><td>19</td><td>0.15</td><td>0.62</td><td>0.909</td><td>0.941</td><td>1.000</td><td>120</td><td>tags=21%, list=16%, signal=24%</td></tr><tr><td class='lessen'>376</td><td>BLALOCK_ALZHEIMERS_DISEASE_DN</td><td></td><td>111</td><td>0.09</td><td>0.61</td><td>0.984</td><td>0.941</td><td>1.000</td><td>229</td><td>tags=34%, list=30%, signal=42%</td></tr><tr><td class='lessen'>377</td><td>KIM_ALL_DISORDERS_CALB1_CORR_UP</td><td></td><td>52</td><td>0.10</td><td>0.60</td><td>0.938</td><td>0.945</td><td>1.000</td><td>275</td><td>tags=48%, list=36%, signal=70%</td></tr><tr><td class='lessen'>378</td><td>SENESE_HDAC3_TARGETS_DN</td><td></td><td>25</td><td>0.13</td><td>0.59</td><td>0.913</td><td>0.951</td><td>1.000</td><td>272</td><td>tags=48%, list=35%, signal=72%</td></tr><tr><td class='lessen'>379</td><td>ONKEN_UVEAL_MELANOMA_DN</td><td></td><td>40</td><td>0.11</td><td>0.59</td><td>0.950</td><td>0.952</td><td>1.000</td><td>687</td><td>tags=100%, list=89%, signal=889%</td></tr><tr><td class='lessen'>380</td><td>FEVR_CTNNB1_TARGETS_DN</td><td></td><td>34</td><td>0.11</td><td>0.57</td><td>0.953</td><td>0.959</td><td>1.000</td><td>58</td><td>tags=12%, list=8%, signal=12%</td></tr><tr><td class='lessen'>381</td><td>PUJANA_BRCA1_PCC_NETWORK</td><td></td><td>108</td><td>0.08</td><td>0.57</td><td>0.992</td><td>0.957</td><td>1.000</td><td>293</td><td>tags=46%, list=38%, signal=64%</td></tr><tr><td class='lessen'>382</td><td>ROZANOV_MMP14_TARGETS_UP</td><td></td><td>18</td><td>0.14</td><td>0.57</td><td>0.953</td><td>0.956</td><td>1.000</td><td>116</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>383</td><td>CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN</td><td></td><td>18</td><td>0.13</td><td>0.54</td><td>0.976</td><td>0.966</td><td>1.000</td><td>8</td><td>tags=6%, list=1%, signal=5%</td></tr><tr><td class='lessen'>384</td><td>NUYTTEN_EZH2_TARGETS_DN</td><td></td><td>44</td><td>0.09</td><td>0.51</td><td>0.982</td><td>0.977</td><td>1.000</td><td>390</td><td>tags=68%, list=51%, signal=130%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>na<b>&nbsp<a href='gsea_report_for_na_pos_1605123464930.tsv'>[plain text format]</a></caption></table></div><br></body></html>